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Summary 
Background: Studies showing that breastfeeding protects against infectious morbidity and 
the significant reduction in HIV transmission through breastfeeding by antiretroviral treatment 
guided the current recommendations favouring breastfeeding which has to be continued until 
12 months of age. Infant feeding guidelines for HIV-infected women in low-resourced 
settings are primarily informed by studies that spend much effort in controlling guideline 
adherence by investigators and participants. These studies however may not reflect the real 
world effects of the feeding options on important outcomes because such efforts are less 
enforced or rear in primary care settings. Reliable studies are lacking for predicting the real 
world effects of the feeding options on infant growth and morbidity to guide healthcare 
authorities in decision making. Social and contextual factors affecting HIV-infected women’s 
infant feeding practices are major barriers to uptake of infant feeding recommendations to 
levels that would result in a significant impact. Yet less attention is paid to these during 
guideline development and implementation. Methods: To address this knowledge gap we 
performed a longitudinal cohort study in primary healthcare settings, over a 12 months 
period. The objectives were to a) describe HIV-infected women’s infant feeding practices b) 
compare infant feeding practices of HIV-infected and HIV-uninfected breastfeeding women 
c) assess growth and infection-related hospitalizations among predominantly breastfed and 
predominantly formula-fed HIV-exposed uninfected infants. We explored infant feeding 
experiences of a sub-set of HIV-infected women who were followed-up for at least 6 months 
post-delivery in the longitudinal cohort. Results: We found that few HIV-infected women 
chose breastfeeding, and among those who did, many switched to formula feeding early. 
The proportion of women who continued predominantly breastfeeding was only slightly lower 
among HIV-infected compared to HIV-uninfected women (p = 0.0005). These differences 
were seen from about two weeks, and persisted throughout follow-up. By about four months, 
half of the HIV-infected women had switched to predominant formula feeding. However, the 
proportion of HIV-uninfected women who switched to formula feeding was also relatively 
high. The dual infant feeding option employed by the Western Cape PMTCT program while 
transitioning from formula feeding policy confused HIV-infected women who were worried 
that their child may contract HIV through breastmilk because of conflicting messages they 
received from healthcare providers, possibly explaining why some women stopped 
breastfeeding. Women’s interpretation of information about risks and benefits of infant 
feeding options, formula feeding stigma and the quality of infant feeding counselling affected 
women’s infant feeding practices. Mean weight velocity Z-scores (95% CI) of predominantly 
breastfed infants was -0.70 (-1.31 to -0.09; p = 0.024) lower than that of predominantly 
formula fed infants in the two to four months age interval. Protection against infections by 
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breastfeeding was minimal and insignificant, odds ratio (OR) 0.95 (95% CI 0.33 to 2.74). In 
conclusion, it is important that all women, whether HIV-infected or not, be educated that 
breastfeeding is the feeding of choice in this setting. The potential of breastfeeding to reduce 
risks of infections to levels similar to those observed under highly controlled settings, 
involves changing women’s infant feeding practices. Strategies to promote and sustain 
continued breastfeeding by women, to levels that would result in a significant impact on the 
growth and protection against infections of their children are urgently needed. The strategies 
should be guided by social and contextual factors affecting women’s feeding practices. 
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Opsomming 
 
Studies toon aan dat borsvoeding beskermend is teen aansteeklike morbiditeit en ook ‘n 
betekenisvolle verlaging in MIV oordrag deur borsvoeding en anti-retrovirale behandeling 
(ARB).  Hierdie feite het daartoe aanleiding gegee tot die huidge aanbevelings van 
borsvoeding as voorkeur tot op 12 maande te gee.  Babavoedingriglyne vir MIV-
geïnfekteerde vroue in lae-inkomste omgewings word primêr gedryf deur studies wat daarin 
poog vir die riglynbeheer toepassing deur navorsers en deelnemers. Hierdie studies mag nie 
noodwendig die werklikheid van voedingsopsies ten opsigte van belangrike uitkomste lewer 
nie omrede verskeie pogings tot ‘n mindere mate toegepas en selfs raar is in primêre 
gesondheidsorgomgewings.  Daar bestaan ‘n leemte in betroubare studies wat die 
werklikheidseffekte van voedingsopsies op babagroei en morbiditeit voorspel, en wat daarin 
poog om gesondheidsorg owerhede se besluitneming te kan beïnvloed.  Sosiale en 
kontekstuele faktore wat MIV-geïnfekteerde vroue se babavoedings keuses beïnvloed, is die 
hoof hindernis om babavoedingaanbevelings deur te voer wat ‘n betekenisvolle impak sal 
maak.  Minder aandag word aan hierdie aspekte tydens die riglynontwikkeling en 
implementering spandeer. Om die kennisgaping romdom hierdie aspek te adreseer het ons 
‘n longitudinale studie in primêre gesondheidsorgeenhede oor ‘n 12 maande periode 
ondersoek.  Die doelstellings was om a) MIV-geïnfekteerde vroue se babavoedingkeuses te 
beskryf b) babavoedingpraktyke van MIV-geïnfekteerde vroue en MIV-nie-geïnfekteerde 
borsvoedende vroue te vergelyk c) groei en infeksie-verwante hospitalisasies onder 
hoofsaaklik borsvoedende en formule voedende MIV-blootgestelde ongeïnfekteerde babas 
in primêre gesondheidsorgomgewings oor ‘n 12 maande periode te evalueer. Ons het 
babavoedingervarings in ‘n sub-groep MIV-geïnfekteerde vroue vir ses maande na bevalling 
in die longitudinale kohort ondersoek.  Resultate: Ons het gevind dat min MIV-geïnfekteerde 
vroue borsvoeding gekies het, en onder die wat wel het, baie vroeg oorgeskakel het na 
formule voeding.  Die aantal vroue wat hoofsaaklik by borsvoeding gehou het is betekenisvol 
minder onder die MIV-geïnfekteerde as die ongeïnfekteerde vroue (p = 0.0005). Hierdie 
verskille is sigbaar teen omtrent twee weke en is regdeur die opvolg waargeneem. Om en by 
vier maande het die helfte van die MIV-geïnfekteerde vroue na hoofsaaklik formule voeding 
oorgeskakel. Die gedeelte van die MIV-geïnfekteerde vroue wat oorgeskakel het na formule 
voeding was ook relatief hoog.  Die dubbel babavoedingopsie, wat deur die Weskaapse 
PMTCT program as opsie gegee word in die oorgangsfase van formule voeding, het MIV-
geïnfekteerde moeders verwar omrede hulle bekommerd was dat hulle kinders deur 
borsmelk MIV mag opdoen weens teenstrydige boodskappe wat hulle van 
gesondheidswerkers ontvang het, kan moontlik verklaar waarom sommige vroue ophou 
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borsvoed het.  Die vroue se interpretasie van die inligting oor risikos en voordele van 
babavoedingsopsies, formule voedingstigma en die kwaliteit van voedingsberading, het die 
moeders se voedingskeuses beïnvloed.  Gemiddelde massa snelheid Z-tellings (95% VI) 
van die meerderheid borsvoedende moeders was -0.70 (-1.31 to -0.09; p=0.024) laer as die 
van die meerderheid formule gevoede babas in die twee tot vier maande ouderdomsinterval.  
Vroue wat formulevoeding gegee het, het verhoogde persepsies oor MIV oordragrisiko deur 
borsmelk gehad.  Teen ses maande ouderdom, het hoofsaaklik borsgevoede babas gewig 
teen ‘n tempo van 0.08 (95% vertrouheidsinterval (VI): -0.14 tot -0.02; p = 0.01) opgetel, 
gewig-vir-ouderdom z-tellings per maand was laer as in die hoofsaaklik formule gevoede 
babas.  Beskerming teen infeksies deur borsvoeding was minimaal en nie betekenisvol nie, 
kansverhouding (KV) 0.95 (95% VI 0.33 tot 2.74). Gevolglik, is dit belangrik dat alle vroue, 
ongeag of hulle met die MIV geïnfekteer is of nie, opgevoed te word dat borsvoeding die 
voeding van keuse is in hierdie omgewing.  Strategieë om borsvoeding deur vroue te 
bevorder, en wat tot betekenisvolle impak op die groei en beskerming teen aansteeklike 
siektes van hulle kinders voort te sit, is uiters noodsaaklik. Die strategieë behoort deur 
sosiale en kontekstuele faktore gerig te word wat vroue se voedingskeuses beïnvloed. 
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Chapter 1 
Introduction 
 
Introduction 
Since the discovery more than 30 years ago, that Human Immunodeficiency Virus (HIV) can 
be transmitted from an HIV-infected woman to her infant through breast milk, information has 
been accumulating to guide infant feeding practices for HIV-infected women in low-
resourced settings. Feeding guidelines are informed primarily by evidence from tightly 
controlled studies evaluating the effects of alternative infant feeding options on important 
clinical outcomes. Most of these studies test the efficacy of the feeding interventions and 
also invest a lot of effort into controlling guidelines adherence of practitioners and 
participants. The limitation of such studies is that the findings may not reflect what happens 
in real world settings, where the same level of effort for ensuring adherence is rare. 
Background 
Previous studies support breastfeeding in minimizing the risks of respiratory and 
gastrointestinal infections, and also malnutrition (1). Exclusive breastfeeding for 6 months 
prevents about 1.3 million (13%) child deaths per year for children less than 5 years, 
compared to formula feeding that prevents 150 000 (2%) of global child death (2). 
Breastfeeding for less than 6 months compared to breastfeeding for more than 6 months 
was associated with poor growth from 4 to 24 months in a randomized controlled trial in 
Zambia (3).  
Prevention of mother-to-child HIV transmission programs (PMTCT) in low-resourced settings 
evaluated the effect of antiretroviral (ARV) interventions in reducing the risk of HIV 
transmission and making breastfeeding safe for HIV-infected women. Between 2006 and 
2010, randomized controlled trials demonstrated a consistent effect of triple combination 
antiretroviral treatment (cART) given either to the HIV-infected woman or HIV-exposed infant 
in reducing HIV transmission during breastfeeding (4-7). These findings dramatically 
changed infant feeding recommendations for HIV-infected women in low-resourced settings, 
with the World Health Organization (WHO) recommending a standardised triple-drug 
regimen during pregnancy and the breastfeeding period, regardless of CD4 count (8,9). 
These recommendations have changed clinical practice even in low-resourced settings with 
high uptake of formula feeding and relatively low rates of breastfeeding by HIV-infected 
women, for example the PMTCT programs in Western Cape Province of South Africa are 
now recommending breastfeeding that has to be continued until 12 months. 
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Study justification 
Studies evaluating the clinical effects of alternative infant feeding options were conducted 
under idealised conditions. Most of these studies devote much effort to controlling guideline 
adherence of practitioners and participants. In real world setting of implementation, the same 
effort of control is rare (10). We previously questioned whether the effects of infant feeding 
interventions from a randomized controlled trial and some tightly controlled observational 
studies could be extrapolated to normal practice settings (11). We previously conducted a 
systematic review to estimate the effects of breastfeeding, formula feeding and other infant 
feeding intervention on improving infant growth and reducing non-HIV infections (11) (see 
Appendix 1). I searched online databases, PubMed, SCOPUS, and Cochrane CENTRAL 
Controlled Trials Register for potential studies to include in the systematic review. 
Randomized trials and prospective cohort studies were included in the review. One co-
author (GM) and I independently extracted data, evaluated risk of bias and assessed the 
quality of evidence of included studies. I also performed the meta-analysis. The review 
showed that breastfeeding HIV-exposed infants reduce the risk of diarrhoea and respiratory 
infections by about 26 and 35%, respectively, through two years of age. Breastfeeding 
tended to protect against malnutrition. We then questioned whether the evidence from this 
review of randomized controlled trials and some tightly controlled observational studies could 
be extrapolated to normal practice settings (11).  We performed a longitudinal cohort study 
to address the question whether predominant breastfeeding compared to predominant 
formula feeding improves growth and reduces infectious morbidity of HIV-exposed 
uninfected infants in primary healthcare clinics. 
Many PMTCT programs in low-resourced settings recently adopted “Option B+” strategy into 
policy, where HIV-infected women are put on triple-cART, irrespective of CD4 count, which 
has to be maintained at least for the duration of breastfeeding or as lifelong treatment. While 
the Option B+ strategy is a sound medical and public health approach, the shift in formula 
policy by Western Cape PMTCT program may not have put much consideration on social, 
and contextual issues affecting HIV-infected women infant feeding practices (12,13).  
Scope of the research 
We performed a longitudinal cohort study on the effects of predominant breastfeeding and 
predominant formula feeding on infant growth and infection-related hospitalizations, among 
HIV-exposed uninfected infants in real life primary healthcare settings. We also explored 
HIV-infected women’s experiences and perceptions on breastfeeding and formula feeding 
during a time when the Western Cape PMTCT program was withdrawing provision of free 
formula milk and starting to provide all HIV-infected women with lifelong cART and 
promoting breastfeeding. The research findings are likely to reflect what happens to a larger 
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population of HIV-infected women and infants born to HIV-infected women, and could 
therefore inform infant feeding policy and practice for HIV-infected women in low-resourced 
settings.  
Objectives 
o To describe HIV-infected women’s infant feeding practices. 
o To determine the effect of predominant breastfeeding and predominant formula 
feeding on improving growth (weight-for-age (WAZ), length-for-age (LAZ), weight-for-
length (WLZ) z-scores) of HIV-exposed uninfected infants in primary healthcare 
settings, over 12 months. 
o To determine the effect of predominant breastfeeding and predominant formula 
feeding on growth velocity (weight velocity Z-scores (WVZ), length velocity Z-scores 
(LVZ)) of HIV-exposed uninfected infants in primary healthcare settings, during the 
first 6 months. 
o To determine the effect of predominant breastfeeding and predominant formula 
feeding on infection-related hospitalizations of HIV-exposed uninfected infants in 
primary healthcare settings, over 12 months. 
o To explore HIV-infected women’s experiences and perceptions on breastfeeding and 
formula feeding during a time when the Western Cape PMTCT program was 
withdrawing provision of free formula milk and started providing all HI-infected 
women with lifelong cART and promoted breastfeeding. 
 
Methods 
We enrolled HIV-infected women and their exposed infants to assess the effect of 
predominant breastfeeding and predominant formula feeding on infant growth and infection-
related hospitalizations over a 12 months period.  
Women who gave birth between July 2012 and December 2013 at Kraaifontein Midwife 
Obstetric Unit, in Cape Town, South Africa, were invited to participate in the study. Women 
could participate if they were at least 16 years of age and delivered at the obstetric unit 
during weekday daytime hours. We evaluated only those women who were HIV-infected, 
had been on Zidovudine (AZT) for ≥ 2 weeks or on cART for ≥6 weeks before delivery; 
women who were pregnant with more than 1 infant were excluded.  Infants were enrolled if 
they had a birth weight of at least 2000g and a gestational age of 36 weeks or more. Mother-
infant pairs were followed for 12 months post-partum at the Children’s Infectious Diseases 
Clinical Research Unit, in Tygeberg Academic Hospital. Final follow-up was completed in 
December 2014. 
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We compared growth (WAZ, LAZ, and WLZ z-scores), growth velocity (WVZ and LVZ) and 
infection-related hospitalizations of HIV-exposed uninfected infants who were predominantly 
breastfed and those who were predominantly formula fed.  
We also explored HIV-infected women’s experiences and perceptions on breastfeeding and 
formula feeding in a sub-sample of HIV-infected women who were followed-up for at least 6 
months post-delivery in the longitudinal cohort. We used Interactive Qualitative Analysis 
methods (IQA); where HIV-infected women described, labelled their experiences, and 
articulated perceived relationships among their experiences.  
The Human Research Ethics Committee of Stellenbosch University approved the main 
protocol and amendment protocol (Ref: S12/03/065). All participants provided a written 
informed consent for study participation. 
Thesis outline 
The thesis comprises 7 chapters. This chapter provides an overview to the reader. 
  
Chapter Two provides a literature review of the study. A review on epidemiology and global 
burden of HIV/AIDS, and antiretroviral medication for treatment and prevention of HIV/AIDS 
is provided. Antiretroviral interventions for prevention of mother-to-child transmission of HIV 
and infant feeding policies for HIV-infected women in low-resourced settings are 
summarized.  
 
Chapter Three: Part A outlines the study objectives and study hypotheses of the longitudinal 
cohort study. The cohort study design and methods employed to evaluate infant growth and 
infection-related hospitalizations outcomes are outlined.  
 
Chapter Three: Part B outlines the study objectives of the qualitative sub-study. The IQA 
methods employed to explore HIV-infected women’s experiences and perceptions on 
breastfeeding and formula feeding are described.  
 
Chapter Four provides the findings and a discussion on effects of predominant breastfeeding 
and predominant formula feeding on growth and infectious morbidity of HIV-exposed 
uninfected infants. 
 
Chapter Five provides the findings and a discussion of HIV-infected women’s experiences 
and perceptions of their infant feeding practices. 
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Chapter Six gives a summary of the main findings, a conclusion and limitations of the study. 
It also highlights implications of study findings on clinical practice and future research. 
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Chapter 2 
Literature Review 
 
Epidemiology and global burden of HIV/AIDS 
The first cases of Acquired Immunodeficiency Syndrome (AIDS) were described in 1981 
among young homosexual men who presented with rare opportunistic infections and 
malignancies (14). A year later, in 1982, the first paediatric cases of AIDS were reported in 
infants whose mothers had risk factors for AIDS (15). In 1983-4, HIV-1, was identified as the 
cause of AIDS (16-18). By 1993, there was a dramatic increase in the number of people 
living with HIV infection globally estimated at 13 million (19). Subsequent global reports 
indicate an increase in the number of people living with HIV of approximately 5 million 
people per decade, with an estimate of 30 million in 2001, 34.9 million in 2011 and 35.3 
million in 2012 (20). 
The geographical distribution of the HIV epidemic varies. Sub-Saharan Africa carries the 
greatest burden (70.8%), with mostly young adults affected (20). Within sub-Saharan Africa, 
southern Africa is affected most with the majority of the 23.5 million people living with HIV in 
sub-Saharan Africa. South Africa had the highest HIV prevalence of 6.1 million people (20). 
South Africa’s national antenatal HIV prevalence rate increased from 0.7% in 1990 to 29.5% 
in 2012 (21).  
Epidemiological patterns for HIV infection in Africa are similar to elsewhere in the world. 
There are more HIV-infected men than women. The reason for unequal distribution between 
genders is unclear, a recent study attributed gender inequality to increased mortality among 
HIV infected men (31% higher) compared to women (22). 
HIV infection contributes considerably to the global burden of disease. In 2010, disability-
adjusted life years among young people (30-44 years) were primarily due to HIV (23). While 
global AIDS related deaths peaked at 2.3 million in 2005, a remarkable decrease to 1.6 
million was reported in 2012 (20). Most (75%) of these deaths were from sub-Saharan Africa 
(20). The decreasing mortality can be attributed largely to the recent increased access to 
ART for HIV-infected people which has changed the epidemiology of HIV infection 
worldwide. About 10 million HIV-infected people in low-income and middle-income countries 
were on ART in 2012 (24), representing 61% of HIV-infected people eligible for treatment 
under the 2010 WHO HIV treatment guidelines (24). Access to treatment for people living 
with HIV/AIDS in low- and middle income countries saved over 4.2 million lives in 2002–
2012 (24). However, with the revisions of the HIV treatment guidelines in 2013, the treatment 
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coverage in low- and middle income countries represented roughly 34% of the 28.6 million 
people eligible for HIV treatment in that year (24). The global prevalence of HIV has 
increased from 31.0 million in 2002, to 35.3 million in 2012, because people on ART are 
living longer (20). A 30% reduction in global rates of new HIV infections (horizontal 
transmission); a decrease from 3.3 million in 2001, to 2.3 million in 2012 was associated with 
increased access to ART (20). More importantly, 26 countries, 16 being in sub-Saharan 
Africa, reported a reduction of new HIV infections of at least 50% between 2001 and 2012 
(20). Despite these achievements, rates of new HIV infections remain high, with 70% 
occurring in sub-Saharan Africa (20).  
HIV-1 transmission and risk factors 
Human immunodeficiency virus type 1 is transmitted through sexual, percutaneous, and 
perinatal routes, with the former being most common (25,26). The main risk factor for sexual 
transmission of HIV-1 is the number of HIV-1 RNA copies (viral load) per mL of plasma. The 
risk increases by 2.4 for every 1 log10 increase in viral load (27). New HIV infection, 
associated with very high plasma viral loads, increases the risk of transmission (26). Other 
risk factors for sexual transmission of HIV include co-existing sexually transmitted diseases 
for example genital ulcers (28), herpes simplex type-2 (29), bacterial vaginosis (30) and 
pregnancy (31). Behavioural risk factors include many sexual partners (32,33). 
Antiretroviral therapy for HIV treatment and prevention 
Suppression of viral replication through cART has changed the poor prognosis of HIV/AIDS 
into a chronic manageable disease (34). HIV treatment guidelines in high-income countries 
recommend initial treatment with dual nucleoside reverse transcriptase inhibitors combined 
with either a non-nucleoside reverse transcriptase inhibitor, a ritonavir-boosted protease 
inhibitor, or an integrase inhibitor (35). Similarly, WHO HIV treatment guidelines for low- and 
middle-income countries recommend first-line ART consisting of two nucleoside reverse 
transcriptase inhibitors and a non-nucleoside reverse transcriptase inhibitor (tenofovir (TDF), 
lamivudine (3TC) or emtricitabine (FTC), and efavirenz (EFV). Combinations with zidovudine 
(AZT) or nevirapine (NVP) are recommended as alternatives, in resource constrained 
settings (8,9). 
Plasma viral load decreases to undetectable levels by commercial assay, within three 
months of starting ART in most people. However, recovery of CD4 T cells varies widely 
among people on ART. Tuboi et al., 2007 reported high variability in virological or CD4 
responses to ART at 6 months; 56% had a successful virological and CD4 response, 19% 
and 15% had only virological  and CD4 response, respectively (36). HIV-infected people with 
poor CD4 T-cell recovery regardless of successful virological suppression have a high risk 
for adverse outcomes, including serious non-AIDS events (37). 
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With improved access to ART and at higher CD4 counts, HIV-infected people will initiate 
ART early and live longer and therefore become increasingly susceptible to chronic 
diseases. About half of the deaths among HIV-infected people on ART in high-income 
countries are not associated with AIDS related disease (38). Main causes of non-AIDS- 
related deaths in these countries were non-AIDS defining cancers (23.5%), heart disease 
(15.7%), and liver disease (14.1%) (38). In contrast, tuberculosis is the main cause of 
morbidity and mortality among HIV-infected people in low- and middle-income countries, 
(39). 
Several studies showed the effectiveness of antiretroviral interventions in reducing the 
spread of HIV at population level. Antiretroviral treatment was associated with a reduction in 
HIV incidence in an HIV-uninfected partner in the HIV prevention trials network (HPTN) 052 
study (40). In the trial, the HIV-infected partner from a sero-discordant couple with CD4 
counts of 350-550 cells per µL was randomly assigned to immediate or deferred ART (when 
CD4 count was <250 cells per µL). Compared to deferred ART immediate ART was 
associated with a 96% reduction in new HIV infections (40). 
The public health impact of ART coverage was reported in a rural setting with high HIV 
prevalence, KwaZulu Natal, South Africa (41). Communities with high ART coverage 
(defined as 30-40% among all HIV-infected people) had a 38% lower risk of getting HIV 
infection compared to communities with ART coverage of less than 10% (41). A 
mathematical model assessing the impact of universal HIV testing and immediate ART for all 
HIV-infected people, predicted a reduction in both HIV incidence and mortality of less than 1 
case per 1000 people per year within 10 years of implementing the strategy, and a reduction 
in HIV prevalence of to less than 1% within 50 years (42). 
As evidence accumulated that starting ART early delays HIV disease progression, the WHO 
revised the ART guidelines in 2013 recommending that ART be started in HIV-infected 
people with WHO clinical stage 1 or 2 and a CD4 count ≤ 500 cells/mm3 and people with 
severe or advanced HIV infection (WHO clinical stage 3 or 4), irrespective of CD4 cell count 
(43). Although ART has reduced HIV transmission and AIDS related deaths, access is not 
universal, especially in low-income countries (20), and the development of vaccines or 
treatments that cure HIV remain uncertain (44,45). Thus, HIV/AIDS will remain a public 
health issue and of concern for paediatric HIV infections for years to come.   
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Prevention of postnatal mother-to-child-transmission of HIV infection through breast-milk 
Infant feeding for HIV–infected women in low-resourced settings 
A series of case reports in 1985-88 provided the first evidence that HIV could be transmitted 
from an HIV-infected mother to her infant through breast milk (46-48). Both HIV infection and 
infant feeding became important public health issues especially in low-resourced settings, 
where breastfeeding has been associated with child survival (49,50). 
Cumulative rates of mother-to-child HIV transmission (MTCT) reflect transmission during 
pregnancy, delivery, or post-delivery through breast milk (51). In non-breastfed infants, about 
30% of HIV infections occur during pregnancy, with the majority (70%) occurring during 
labour and delivery (52,53). HIV transmission rates from an HIV-infected mother to her 
formula fed infant, with no treatment ranged from 14-32% in high-income countries 
compared to 25-48% among infants in low-income countries who are mostly breastfed (54). 
With no ART, the risk of HIV transmission is about 1.57% per month of breastfeeding when 
maternal CD4 count is low (<350 cell/ml) versus 0.51% when maternal CD4 count is higher 
(55). This converts to a cumulative postnatal HIV transmission risk of 14-20% at 2 years of 
age, among infants of HIV-infected mothers. New HIV infection increases the postnatal 
transmission risk to about 28% irrespective of the duration of breastfeeding (56).  
 
As early as 1992, high-income countries had settled on an infant feeding policy for HIV-
infected women, where avoidance of breastfeeding and use of safe alternatives was 
recommended (57). Following use of ART, caesarean section and formula milk, MTCT of 
HIV was reduced to below 2% in high-income countries (58). In 2001, the WHO 
recommended formula feeding for HIV-infected women in low-resourced settings based on 
experiences from high-income countries (59). The guidelines recommended formula feeding 
on condition that it is acceptable, feasible, affordable, sustainable and safe (AFASS criteria). 
Exclusive breastfeeding was recommended as an alternative when the AFASS criteria were 
not met (59). HIV-infected women who chose to exclusively breastfeed on discontinuation of 
breastfeeding had to stop abruptly within the first 4-6 months. However, the drawback of 
rapid weaning was increased risk of infant morbidity. 
At the end of 2005 about 2.3 million children less than 15 years of were living with HIV, 
700,000 new infections were reported in children, mostly through MTCT and 570,000 AIDS 
associated deaths were reported (60). The urgency for preventing new HIV infections in 
children in low-income countries grew. In 2005, the Inter-Agency Task Team on prevention 
of mother-to-child transmission (PMTCT) and Paediatric HIV brought together governments, 
donors and partners to the PMTCT Global Partners Forum in Abuja, Nigeria (61). A call to 
eliminate HIV infection in infants and children was made (61). In late 2005, Joint United 
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Nations Programme on HIV/AIDS and United Nations Children Fund launched a campaign 
supporting universal access to treatment and assessment of the impact of HIV/AIDS on 
children (62).  
After 2001, a number of studies conducted among breastfed and non-breastfed infants 
showed efficacy of short course antiretroviral drug combination given during pregnancy and 
post-delivery in reducing the risk of MTCT of HIV. The short course antiretroviral 
combinations included AZT + 3TC (63-65), AZT + single dose nevirapine (Sd-NVP) (66-68), 
or AZT and 3TC + Sd-NVP (67). Based on these findings the WHO updated infant feeding 
guidelines in 2006 (69). The principles of the guidelines were similar to those of the 2001 
guidelines. HIV-infected women were recommended to get either ART or prophylaxis to 
prevent MTCT, depending on whether they had indications for ART for their own health (69). 
The guidelines specified how the recommended regimens were to be taken during 
pregnancy, delivery, and post-delivery. Infant feeding option for HIV-infected women 
considered the individual situations of the woman, which included woman’s health status, 
and health services available. Both 2001 and 2006 guidelines recommended avoidance of 
breastfeeding if the AFASS criteria were met, otherwise HIV-infected women had to 
exclusively breastfeed for the first six months. 
Overwhelming evidence supports breastfeeding in reducing infant morbidity and mortality in 
resource-poor settings, by minimizing the risks of respiratory and gastrointestinal infections 
and also malnutrition (1). About 1.3 million (13%) child deaths per year of children less than 
5 years are prevented, if most (90%) of infants less than 6 months are exclusively breastfed, 
whereas, avoidance of breastfeeding prevents 150 000 (2%) of global child death (2). 
Important findings were reported in a study in South Africa, where exclusive breastfeeding 
up to six months reduced MTCT of HIV rate to 4%, (70). The same study reported lower 
mortality rates in exclusively breastfed infants (6.1%) compared to formula fed infants 
(15.1%) (70). In addition, breastfeeding for less than 6 months was associated with 
increased infant mortality and poor growth from 4 to 24 months in a randomised controlled 
trial in Zambia (3). Another study showed a reduction in infant survival when women 
shortened the duration of breastfeeding (71).  
The major drawbacks of the 2001 and 2006 WHO infant feeding guidelines were that most 
HIV-infected women in low-resourced settings could not meet the criteria to formula feed. 
Few research findings showed that formula feeding reduced mortality and improved HIV-free 
survival among HIV-exposed infants in low resourced settings (72). The need to develop 
ART interventions that reduce the risk of HIV transmission through breast milk was realised. 
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Antiretroviral interventions to reduce HIV transmission through breast milk 
Studies were conducted in low-resourced settings between 2006 and 2010 with ART given 
either to the HIV-exposed infant or HIV-infected woman, for a longer duration, to reduce the 
risk of HIV transmission through breast milk. These included the Breastfeeding, 
Antiretrovirals and Nutrition (BAN), Post-Exposure Prophylaxis of Infants (PEPI) (7,73,74), 
Six-Week Extended-Dose Nevirapine (SWEN) (75), and HIV Prevention Trials Network 
(HPTN 046) (76) trials. In 2008, the SWEN study reported a 0.54 risk reduction of HIV 
transmission in HIV-exposed infants receiving a 6 week regimen of daily NVP compared to 
infants receiving a single dose of NVP (75). Kumwenda et al., reported similar findings in 
2008 (77). HIV-exposed infants were randomly assigned to one of the three regimens; Sd-
NVP plus 1 week of AZT (control regimen) or the control regimen plus daily extended 
prophylaxis either with NVP (extended NVP) or with NVP and AZT (extended dual 
prophylaxis) until the age of 14 weeks (77). At 9 months, HIV-1 infection was 10.6% in the 
control group, 5.2% in the extended-NVP group (p<0.001) and 6.4% in the extended-dual-
prophylaxis group (p = 0.002) (77). In HPTN 046, NVP given to infants until 6 months of age 
almost halved HIV infection rates between 6 weeks and 6 months compared to placebo 
(1.1% versus 2.4%) (76). The study also reported a reduction in risk of HIV transmission 
through breast milk among women on lifelong ART for their own health, irrespective of 
whether their infants had received NVP or placebo (76). Women’s CD4 count was a 
significant risk factor of postnatal HIV transmission through breast milk (76). The study 
reported similar HIV transmission rate of about 1% among infants (on NVP) of women on 
lifelong ART for their own health and infants of women not on lifelong ART with high CD4 
count (at least 350 cells/ml) (76).  
Following the success of triple-cART in reducing the risk of MTCT during pregnancy and 
labour to below 2% in high-income countries (78-80), low-income countries started 
evaluating the effect of triple-cART in reducing the risk of postnatal MTCT of HIV through 
breast milk. The MmaBana and Kesho Bora studies found very low HIV transmission rates 
through breast milk, irrespective of HIV-infected women’s eligibility for lifelong cART for their 
own health (4,5). The Mitra and BAN studies reported similar findings with extended infant 
antiretroviral prophylaxis or maternal triple-cART (6,81). 
 
Triple-cART reversed the increasing trend of the paediatric HIV infections in low-resourced 
settings. A decrease of 38% in new paediatric HIV infections, between 2009 and 2012 was 
associated with improved ART access for PMTCT (24). Over 900 000 HIV-infected pregnant 
women were on ART at the end of 2012, worldwide (24). Antiretroviral treatment coverage in 
PMTCT programs increased from 59% in 2011 to 62% in 2012, in 22 priority countries, 
which are home to about 90% of pregnant women with HIV, globally (24). Botswana, Ghana, 
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Namibia and Zambia are among other countries already providing ART to the majority (90%) 
of HIV-infected pregnant women. However, antiretroviral coverage was lower during the 
breastfeeding period (49%) than during pregnancy and delivery (62%) in 2012 (24). 
Nevertheless, because of increased access to cART for PMTCT in low-resourced settings, 
only 260 000 children were newly infected in 2012, 35% lower than in 2009 (20). 
 
The infant feeding guidelines for low-resourced settings were further revised to minimise the 
risk of HIV transmission based on studies that had shown that cART or prophylaxis given 
either to the woman or her infant reduce the risk of HIV infection through breast milk. The 
WHO guidelines of 2010 and 2013 took into consideration provision of cART to the HIV-
infected woman either for a recommended period or for life, respectively (8,9). The current 
guideline (WHO 2013) (9), recommends triple-cART, irrespective of woman’s CD4 count, 
which has to be maintained at least for the duration of breastfeeding or as lifelong treatment, 
also called “Option B+” (9). 
The infant feeding guidelines for HIV-infected women in low-resourced settings evolved from 
no breastfeeding to breastfeeding with rapid weaning at 4-6 months and now, breastfeeding 
for at least 1 year with triple-cART covering the pregnancy, delivery and post-delivery MTCT 
risk period. The feeding guidelines for HIV-infected women in low-resourced settings are 
informed primarily by evidence from an explanatory randomized controlled trial (116) and 
tightly controlled observational studies. These studies evaluated the effects of alternative 
infant feeding options for HIV-infected women, on infant growth and morbidity, under tightly 
controlled conditions (11). Most of these studies devote much effort to controlling guideline 
adherence of investigators and participants. 
What is known in the South African context? 
An ongoing debate issued among those supporting and those against breastfeeding for HIV-
infected women, because of the confusion around the risk of HIV transmission through 
breast milk. Two aspects complicated this situation further. Firstly, in most communities in 
low-resourced settings, breastfeeding is a symbol of good motherhood; and the second 
aspect relates to the commercial interests of food industries that are likely to benefit from 
promoting formula feeding (82).  
The South African PMTCT program adopted the 2010 WHO guidelines (83). At the time, 
however, the guidelines promoted both exclusive breastfeeding and formula feeding. 
Healthcare authorities from different provinces differed on the feeding option they supported, 
with most provinces supporting exclusive breastfeeding and a few supporting formula 
feeding. The Western Cape Province provided free commercial formula milk, for 6 months to 
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HIV-infected women whose initial choice was not to breastfeed. Formula feeding had a high 
uptake (>70%) with relatively low rates of breastfeeding, in the province. Two years later, in 
2012, the Western Cape PMTCT program transitioned from formula feeding policy to 
providing HIV-infected women with lifelong cART and promoting breastfeeding. During the 
transitional period, HIV-infected women were counselled by primary healthcare nurses and 
trained lay counsellors to choose between exclusive breastfeeding and formula feeding. The 
guidelines were further updated in March 2013 recommending a standardised triple-cART to 
treat HIV-infected pregnant and breastfeeding women, regardless of CD4 count, with 
continuation of cART after breastfeeding for women with CD4 counts less than 350 (84).  
Knowledge gaps 
Exclusive breastfeeding is the reference feeding methods against which all other infant 
feeding methods must be measured with regard to infant growth and morbidity. However, 
neither exclusive breastfeeding nor exclusive formula feeding is the cultural norm in most 
African settings (85, 86). For example, majority (>80%) of South African women initiate 
breastfeeding but only 26% of the women report exclusive breastfeeding in the first 6 months 
(87). Many factors, including practical, economic, social, psychological and cultural 
challenges have been associated with suboptimal infant feeding practises (88, 89). Poor 
counselling has been linked to these challenges (90). In addition, the risk of HIV 
transmission through breast milk has made infant feeding practices complex in the context of 
HIV (91).  
Feeding modality is central to achieving optimal growth and health of infants born to an HIV-
infected woman, but of concern is the emerging evidence showing that HIV-exposure may 
also influence health outcomes of HIV-exposed uninfected infants (92, 93). There are many 
possible ways that could increase the risk for poor health outcomes of an HIV-exposed 
uninfected infant. The HIV-exposed foetus is exposed to maternal HIV and to antiretroviral 
drugs in-utero (94). Often HIV-exposed infants are exposed to other infectious agents, 
including Mycobacterium tuberculosis, than HIV-unexposed infants and all these contribute 
in varying degrees to poorer health outcomes (95-97). HIV-exposed infants including 
uninfected infants are exposed to long courses of ARV drugs, and the effects of the drugs on 
HIV-exposed uninfected infants’ growth are not well established (93).  
Two studies conducted in Africa comparing HIV-exposed uninfected to HIV-unexposed 
uninfected infants for all-cause mortality or infectious morbidity (98,99), found increased 
morbidity in HIV-exposed uninfected infants, however, other studies conducted prior to ART 
era concluded that HIV-exposed uninfected infants were no different from HIV-unexposed 
uninfected infants for morbidity and mortality (100,101). However, most of the evidence from 
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the pre-ART era, suggests that HIV-exposed uninfected infants experience greater morbidity 
and mortality than HIV-unexposed uninfected infants. 
Many PMTCT programs in high prevalent settings including the Western Cape, rapidly 
adopted Option B+, where until recently there was high uptake of formula feeding and 
relatively low rates of breastfeeding by HIV-infected women. The feeding guidelines are 
informed primarily by evidence from tightly controlled studies. These studies evaluate the 
effects of alternative infant feeding options on important clinical outcomes under highly 
controlled conditions. The limitation of such studies is that the findings may not reflect what 
happens in real life settings, where the same level of control is unlikely (10). 
Despite the current recommendations to provide lifelong cART and promote breastfeeding 
among HIV-infected women, there are limited data on growth and morbidity of HIV-exposed 
uninfected infants in normal practice settings. Furthermore, the Western Cape PMTCT 
program provided free infant formula for HIV-exposed infants until the age of 6 months. Yet 
there is no published data on health outcome of these infants after free formula supply was 
stopped. 
Moreover, the implementation of HIV infant feeding guidelines has been a challenge in many 
low-resourced settings (12). While the Option B+ strategy is a sound medical and public 
health approach, the shift in formula policy by Western Cape PMTCT program may not have 
given much consideration to social, and contextual issues affecting HIV-infected women’s 
infant feeding practices (12,102). 
Conceptual framework 
We found that some factors have a substantial influence on infant feeding and related health 
outcomes in the context of HIV: 
• Infant feeding practices 
• Socio-demographic and cultural backgrounds 
• social and contextual factors influencing HIV-infected women’s infant feeding 
perceptions and practices 
• Effort invested in controlling infant feeding guideline adherence of HIV-infected 
women and healthcare providers (context) 
The framework that emerged from the theoretical overview presented in this chapter is that 
infant feeding and its influence on health outcomes is complex and consists of a number of 
factors that are both related and interdependent (see Figure 2.1). The model portrays four 
variables that reflect their interdependency within the infant feeding context. Each variable 
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contribute in part to the interactional relationships, and the interaction of the variables 
overall, helps to explain the influence of infant feeding on infant health outcomes. 
 
 
 
 
 
 
 
 
 
Figure 2.1 Theoretical overview of the influence of infant feeding on HIV-exposed uninfected infants’ 
health outcomes 
We performed a longitudinal cohort study on the effects of predominant breastfeeding and 
predominant formula feeding on infant growth and infection-related hospitalizations, among 
HIV-exposed uninfected infants in primary healthcare settings. We also explored HIV-
infected women’s experiences and perceptions on breastfeeding and formula feeding during 
a time the Western Cape PMTCT program was transitioning to providing all HIV-infected 
women with lifelong cART and promoting breastfeeding.  
 
 
 
 
 
Maternal HIV-infection HIV-exposed uninfected infant 
Infant feeding practices 
Social, contextual and 
medical-related factors 
Infant growth and 
infectious morbidity 
Context: 
Real world versus 
tightly controlled 
settings 
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Chapter 3 
Part A: Mother Infant Health Cohort Study 
Introduction 
The two studies were planned in phases. The aim of the qualitative study was briefly stated 
in the longitudinal cohort study main protocol. At a later stage, during evaluation of the 
longitudinal cohort study, the qualitative study was added as an amendment to the main 
protocol (approved by ethics committee). The longitudinal cohort study addressed the 
questions: i) whether breastfeeding practices of HIV-infected and uninfected women were 
different and ii) whether predominant breastfeeding compared to predominant formula 
feeding improves growth and reduces infection-related hospitalizations of HIV-exposed 
uninfected infants in infants from the same community setting. 
I developed the research questions for the two studies and contributed in conception and 
design of both the cohort and the qualitative studies. 
Aims 
The study aim was to determine the effect of feeding practices on infant growth and 
infectious morbidity in a real world setting of implementation. 
Primary objectives  
1. Describe HIV-infected women’s infant feeding practices in a real setting of 
implementation 
2. Compare infant feeding practices of HIV-infected and HIV-uninfected (included in the 
Mother-Infant Health study) women, whose initial choice was to breastfeed 
3. To determine the effect of predominant breastfeeding and predominant formula 
feeding in improving growth (weight-for-age (WAZ), length-for-age (LAZ), weight-for-
length (WLZ) z-scores) of HIV-exposed uninfected infants in primary healthcare 
clinics, over 12 months. 
4. To determine the effect of predominant breastfeeding and predominant formula 
feeding on weight velocity Z-scores (WVZ), length velocity Z-scores (LVZ) of HIV-
exposed uninfected infants in primary healthcare settings, during the first 6 months 
 
The null hypotheses were that the growth of HIV-exposed uninfected infants who 
were predominantly breastfed was similar to that of predominantly formula fed 
infants.   
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5. To determine the effectiveness of predominant breastfeeding and predominant 
formula feeding in reducing the odds of infection-related hospitalizations of HIV-
exposed uninfected infants in primary healthcare clinics, over 12 months. 
 
The null hypothesis was that HIV-exposed uninfected infants who were 
predominantly breastfed had similar infection-related hospitalizations to 
predominantly formula fed infants. 
 
Methods and Design 
Study design 
We established a longitudinal cohort study of HIV-infected women and their exposed infants. 
Neither breastfeeding women nor their infants were matched with women and infants in the 
formula feeding group in any way. However, possible confounders such as socio-
demographic and clinical characteristics were assessed and later tested to see if there were 
any significant differences between the groups (see Figure 3.1 Study design sketch). This 
was part of a larger study, the Mother-Infant Health Study that was comparing infection-
related hospitalizations among HIV-exposed uninfected (n = 94) and HIV-unexposed infants 
(n = 82). The main objective of the Mother Infant Health Study (MIHS) was the effect of HIV 
exposure on infection-related morbidity in the first 6 months of life (primary objective) and at 
12 months (secondary objective). Infant feeding was a covariate, whereas, this study closely 
evaluated infant feeding practices for which the MIHS had no data. HIV-uninfected women 
were the comparative group in the MIHS and their breast feeding patterns were included in 
our study to contrast with those of the HIV-infected women. 
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Figure 3.1 Study design: Exposure groups according to intended infant feeding option at enrolment  
Participants and setting 
Women from four suburbs (from Kraaifontein midwife obstetric unit drainage area) with 
comparable low socioeconomic status, who gave birth between July 2012 and December 
2013 at Kraaifontein Midwife Obstetric Unit, a primary healthcare unit in an underserved 
HIV-infected women and their infants were selected according 
to the eligibility 
Enrolled 
Excluded: Inclusion criteria 
not met (see Table 3.1) 
A target sample size of at 
least n=188 HIV-infected 
women and their HIV-
exposed uninfected infants on 
breastfeeding and formula 
feeding 
Exposure groups (mothers self-
selected infant feeding practice) 
HIV-infected women and their HIV-
exposed infants: Breastfeeding (n = 94) 
HIV-infected women and their HIV-
exposed infants: Formula feeding (n = 94) 
Baseline assessment: 
• Socio-demographic 
data 
• Clinical data (ART) 
Baseline assessment: 
• Socio-demographic 
data 
• Clinical data (ART) 
 
Follow-up (2week; 2, 4, 6, 9, 
12 month of age): 
• Health assessment 
• Infant feeding 
practices 
• ART adherence 
• Weight, length 
measurements 
• Hospitalization for 
illnesses 
Follow-up (2week; 2, 4, 6, 9, 
12 month of age): 
• Health assessment 
• Infant feeding 
practices 
• ART adherence 
• Weight, length 
measurements 
• Hospitalization for 
illnesses 
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community in Cape Town, were invited to participate in the study.  Women could participate 
in the study if they were at least 16 years of age and delivered at the obstetric unit. We 
evaluated HIV-uninfected women and women who were HIV-infected, had been on AZT for 
≥ 2 weeks or on cART for ≥ 6 weeks before delivery; women who were pregnant with more 
than 1 infant were excluded.  Infants of HIV-infected women were enrolled if they had a birth 
weight of at least 2000g and a gestational age of 36 weeks or more (see Table 3.1 Study 
eligibility criteria). 
Three quarters of women delivering at the unit are black Africans with the remainder being 
coloured. At the beginning of study recruitment (15 July 2012), about 75% of HIV-infected 
women preferred formula feeding as their infant feeding practice, with 25% choosing 
breastfeeding with ARV treatment (personal communication – Dr Amy Slogrove, 18 May 
2011).  
Primary healthcare nurses screen pregnant women for HIV infection from 14 weeks of 
gestation through voluntary HIV counselling and testing services offered to all women 
seeking antenatal care at the healthcare facility. HIV prevalence was approximately 15% 
among women attending antenatal care in the district (21). Nurses ensure the following: 
PMTCT program entry for HIV-infected women, continuity of prophylactic and ART, and 
initiation of their neonates with antiretroviral prophylaxis. During the study, HIV-infected 
women were counselled to exclusively breast- or formula feed their infants for the first 6 
months of life (83). Primary healthcare nurses provide ongoing post-partum care that 
includes supporting women on their infant feeding practices. HIV-exposed infants receive 
cotrimoxazole preventive therapy from six weeks after birth until HIV infection is excluded 
and breastfeeding has stopped, to reduce the risk of Pneumocystis jirovecii pneumonia 
related-death (9). 
Participants were provided R100 (~US$10) at each follow-up visit to compensate for their 
time, as well as transportation reimbursement.  
The study inclusion and exclusion criteria is shown in Table 3.1 below 
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Table 3.1 Study eligibility criteria  
            Inclusion criteria             Exclusion criteria 
o HIV-infected women who intended to 
formula feed for at least six months 
o Infants born before arrival to the 
obstetric unit 
 
 
o HIV-infected women who intended to 
breastfeed with ART for about one year 
o HIV-uninfected women (in the main study) 
who intended to breastfeed 
o HIV-uninfected women (taking part in the 
Mother Infant Health Study) who intended to 
breastfeed 
o Women who never attended antenatal 
clinical care 
 
o Women at least 16 years of age o Women with unknown or indeterminate 
HIV status 
 
o Infant with no evidence of clinically 
significant health conditions (cardiac, 
respiratory, hepatic, gastrointestinal, 
endocrine, renal, haematologic, neurologic, 
or allergy) requiring care as assessed by the 
healthcare provider i.e. infant was judged to 
be in good health and was discharged after 
delivery) 
o HIV-infected women on AZT started < 2 
weeks before giving birth 
 
o Infant with birth weight <2000g 
 
 
 
o Willingness to participate in all follow-up 
study visits, all clinical examinations and 
agreement for venepuncture for laboratory 
blood tests of their babies 
o HIV-infected women on cART < 6 weeks 
before giving birth 
 
o Women giving birth at Kraaifontein midwife 
obstetric unit 
o Women from low income suburbs of 
Kraainfotein MOU drainage area 
o Pregnant women with >1 infant 
 
 o Gestational age of < 36 weeks at birth 
 
 o Women who required intensive care or 
admitted to a hospital for care 
 
 o Sick new born hospitalized or referred 
for further management 
 
o Women who could not attend follow-up 
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study visits 
o Women enrolled in an HIV-vaccine study 
 
 
Data collection and study follow-up 
Data collection tools included a baseline questionnaire at enrolment, and follow-up 
questionnaires used at 2 week, 2, 4, 6, 9 and 12 months post-delivery). Follow-up data 
collection tools included; biological specimen case report forms, hospitalization case report 
forms, mother-infant health assessment and infant feeding questionnaires.  
Enrolled women signed the consent to participate in the study and later follow-up. Consent 
was obtained in woman’s local language. All women received a study information sheet that 
included details of; study aims, study procedures, and potential benefits and risks of 
participating in the study, decisions to withdraw from the study at any time without any 
change in care, study funding sources, and institutional affiliations of investigators. 
Mother-infant pairs were followed-up at KID-CRU, in Tygerberg Academic Hospital. 
Research nurses took biological specimens and anthropometric measurements. Infant 
feeding questionnaires were completed by research counsellors. A study physician 
physically examined the infants and completed the mother-infant health assessment 
questionnaire at each study visit. Infants with health problems were referred either to 
Tygerberg Children’s Hospital or to their local clinics for medical management, depending on 
the severity of the illness.  
Questionnaires were administered in English, Xhosa or Afrikaans. In instances where study 
participants could speak only one local language, and the research staff could not speak the 
participant’s language, one of the research team would translates questions directly. 
The week before each study appointment, women were reminded telephonically about their 
scheduled study visits. Participants were provided with transport at follow-up visits. Follow-
up data collection was completed on 5 December 2014. 
Participant Retention 
The following strategies were used to maintain adequate follow-up; contact details of 
participants and their next of kin were updated at each follow-up visit, telephone calls to 
those who missed study visits followed by home visits, free doctor consultations and physical 
examination of the child, telephone reminders, research team considered participants’ 
working schedules when setting study appointments, free transports to and from research 
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sites, and ensured referral to specialised clinics when a condition requiring special care was 
identified. 
Data sources and methods of measurement 
Explanatory variables 
Baseline maternal demographic, socioeconomic characteristics and clinical data were 
obtained by data abstraction from maternity case records and by interviewing the woman 
and these included: maternal age, marital status, highest level of education attained, birth 
history, HIV-infection status. 
Antiretroviral treatment was given to the woman or the infant, depending on women’s clinical 
indications. Participants collected their ART and infant formula milk from their local clinics. 
During follow-up visits we assessed infant immunization history, and women’s adherence to 
cART. The immunization history was abstracted from road to health booklets. Self-reported 
adherence to ART or prophylaxis was assessed using a Likert scale assessing levels of 
adherence (from very poor to excellent) in the previous month, and this was based on a tool 
by Chaiyachati et al., 2012 (103). 
Exposure variables 
Infant feeding practice was treated as a time changing exposure variable and was therefore 
determined at enrolment and at each follow-up visit. The two exposure groups comprised of: 
predominantly breastfed and predominantly formula fed HIV-exposed uninfected infants. The 
study was conducted when the Western Cape PMTCT program was transitioning from 
formula feeding policy to providing all HIV-infected women with lifelong cART and promoting 
breastfeeding. HIV-infected women had a choice between exclusive breastfeeding and 
subsidized formula feeding during this transitional period. Free formula milk for 6 months 
was available to all HIV-infected women when the PMTCT program supported formula- 
rather than breast-feeding and during the transitional period (2002 – 2013). The mother 
decided on feeding practice during her interactions with the public program. The researcher 
accepted the mother’s choice and recruited into the appropriate feeding group and 
supported mother’s adherence to her infant feeding practice.  
At each follow-up visit, research staff administered an infant feeding questionnaire. I 
developed the questionnaire based on a WHO standardized instrument (104), which inquired 
about feeding practices during the previous 24 hours and during the prior week. One week is 
suggested as the maximum recall period to obtain reasonably accurate data on infant 
feeding practices. The dynamics of infant feeding are acknowledged to be complex and 
difficult to capture, feeding practices may have changed between follow-up visits (104) and 
this is acknowledged as a limitation of the study. 
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HIV testing of infants was done at 2 weeks and 6 months using a DNA polymerase-chain-
reaction assay (PCR) and at 12 months using an enzyme-linked immunosorbent assay 
(ELISA). A DNA PCR confirmatory test was performed on infants who had reactive ELISA 
test results. All testing was performed at the National Health Laboratory Services at 
Tygerberg Hospital. 
Infant feeding practices were defined according to WHO: (104) 
1. Predominant breastfeeding: Infant receiving mainly breast milk as well as other liquid 
or solid foods, but not formula milk.  
2. Predominant formula feeding: Infant receiving mainly formula milk and other liquid or 
solid based foods, but not breast milk. 
3. Exclusive breastfeeding from birth up to 6 months of age: Feeding practices where 
an infant received only breast milk and no other liquids or solids, including water, but 
may have received drops or syrups consisting of vitamins, mineral supplements, or 
medicines that were considered necessary and essential for the child.  
4. Exclusive formula feeding from birth up to 6 months of age: Feeding practices where 
an infant received only infant commercial formula and no other liquid or solid, 
including water, but may have received drops or syrups consisting of vitamins, 
mineral supplements, or medicines that were considered necessary and essential for 
the child. 
5. Mixed feeding: Breastfeeding as well as giving other milks (including commercial 
formula or home–prepared milk) and other liquid and solid based foods. 
Outcomes variables 
The outcomes were measured at each study visit over the 12 months period. 
Infant growth 
Infant weight was measured using a digital scale and length measurements were taken while 
infants were lying down, using a length board. WAZ, LAZ, and WLZ were estimated using 
WHO 2006 growth standard (105). 
Infection-related hospitalization 
Mothers self-reported infant hospitalizations related to any illnesses, during interviews with 
the study physician. In addition, we searched the national health information service system 
(Clinicom) to identify any hospitalizations that occurred among enrolled infants. With another 
investigator I abstracted information on reason for admission from the medical records. A 
study hospitalization chart abstraction guide (see Appendix 2) was used and the abstracted 
information was recorded on de-identified standardized case report forms.  
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Two paediatricians who were unaware of the feeding mode of the infants reviewed the 
abstracted information and independently classified the hospitalizations using an infection 
classification tool. The infection classification tool, Paediatric Infectious Event Tool for 
Research (see Appendix 3) was designed and validated based on published guidelines 
(106-110).  
Data management 
Data were transcribed from the paper format into an online electronic database 
(OpenClinica). The data were checked to ensure that entered values were acceptable, 
required fields were entered, and items were consistent with other related items in the 
database. I verified the source documents for any discrepant entries that were generated in 
the validation reports. I sent queries electronically to the data manager to address the 
discrepant entries and this continued until the queries were resolved. A record of the 
database update was kept, identifying information about the person who made the changes, 
date, changed values and comments. R program (version 3.1.2) was used to develop the 
program for the validation checks. 
Sample size and power justification 
Assuming mean WAZ-scores (standard deviations) (SD) of 0.17 (0.95) and 0.61 (1.17) in 
predominantly formula fed and predominantly breastfed infants, respectively, 188 HIV-
exposed uninfected infants were required, to reject the null hypothesis that WAZ- scores at 6 
months of age, were similar between the 2 groups, with probability (power) of 0.80, with half 
in the breastfeeding group and the other half in the formula feeding group. The mean (SD) 
WAZ-scores were based on two South African studies (111,112).  
Statistical Methods 
Only HIV-exposed infants who remained HIV-1 negative by PCR or ELISA test and had at 
least one follow-up visit were included in analysis.  
T-test was used to compare the distribution of baseline continuous variables between 
breastfeeding and formula feeding groups. Categorical variables were compared between 
the two feeding groups using Pearson’s chi-square or Fisher’s exact test.  
The 2006 WHO growth standards were used to calculate WAZ, LAZ and WLZ at each study 
visit (105). Hypotheses tests were 2-tailed with level of significance set at p < 0.05. The 95% 
CIs were used to estimate parameters. Stata (StataCorp. 13. Stata Statistical Software: 
Release13. College Station, TX: StataCorp LP) was used for analyses. A summary of 
methods of analysis for each outcome variable is provided in Table 3.2 below. I performed 
the statistical analyses with help of a statistical mentor, Prof Rhoderick Machekano. 
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Table 3.2: Variables, Measures and Methods of Analysis 
Variable/Outcome Hypothesis Outcome Measure Methods of Analysis 
a) Infant growth at each 
study visit 
 
 
 
 
Breastfeeding 
improves growth  
 
 
WAZ-scores 
[continuous] 
LAZ-scores [continuous] 
WLZ-scores 
[continuous] 
t-test 
 
b) Infant growth velocity 
(increments per age 
interval) 
Breastfeeding 
improves growth 
velocity 
WVZ [continuous] 
LVZ [continuous] 
t-test, multiple linear 
regression 
c) Infection-related 
hospitalizations over 
12 months 
 
 
 
Breastfeeding reduces  
infection-related 
hospitalizations 
Infection-related 
hospitalization 
[binary] 
 
 
Mixed effects logistic 
regression 
  
Ethical aspects 
The study was approved by the Human Research Ethics Committee of Stellenbosch 
University (Ref: S12/03/065). Permission to conduct the study was obtained from the 
Western Cape Department of Health (Ref: RP 22/2012). The study was conducted according 
to the ethical guidelines and principles of the International Declaration of Helsinki, South 
African Guidelines for Good Clinical Practice and the Medical Research Council (MRC) 
Ethical Guidelines for Research. All participants provided a written informed consent for 
study participation. Note: We did not get assent for women below the age of 18 years but the 
Human Research Ethics Committee gave permission to consent women from age 16 years 
and above although there was one woman below 18 years.   
All study participants, irrespective of their feeding practice, received health services and 
treatment according to the respective provincial guidelines applicable in the sector at the 
time the study was executed, and no deviation from existing guidelines was caused by 
taking part in this study. 
Potential risks for this study included the possibility of loss of confidentiality concerning HIV 
status of the mother and that of the infant and other identifiable data. Standardized 
procedures were maintained by the research term to ensure participants’ confidentiality. 
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Information received from participants was not disclosed with a third party. This being an 
observational study; there were no physical risks involved in the study. Participants were 
insured by Stellenbosch University’s research policy in the event of physical injury as a direct 
result of study participation.  
All study questionnaires in paper format are stored in safe locked cabinets at KID-CRU, 
Tygerberg Hospital. The electronic database is secure and only accessible to the research 
team through a user name and password. Statistical analyses of the study results were 
presented in aggregate format in technical reports and conference proceedings. 
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Part B: Qualitative study design 
HIV-infected women’s perception and reaction to infant feeding practices 
 
Introduction 
The longitudinal cohort study assessed the effect of predominant breastfeeding and formula 
feeding on improving infant growth and reducing the risks of infection-related 
hospitalizations. Often, however, it is insufficient to have only information about the effect of 
an infant feeding option on clinical outcomes to inform both those affected or healthcare 
decision makers. The qualitative analysis gives a rigorous description of the subjective 
experiences HIV-infected women had with the recommended feeding options. In 
combination with the longitudinal cohort study, the qualitative analysis provides contextual 
and social factors affecting women’s feeding practices that may relate directly to its uptake in 
a real world setting. The aim of the qualitative sub-study was to explore HIV-infected 
women’s experiences and perceptions on breastfeeding and formula feeding during a time 
when the Western Cape PMTCT program was transitioning to providing all women with 
lifelong cART and promoting breastfeeding. 
Study methods 
Participants 
A sub-set of HIV-infected women participating in the longitudinal cohort study was invited to 
participate in a breastfeeding and formula feeding focus group discussion and individual 
qualitative interviews. HIV-infected women who were followed-up for at least 6 months post-
delivery in the longitudinal cohort were eligible to participate in the qualitative study. Study 
participation was not restricted by women’s language. The women were contacted by 
telephone and invited to participate. The qualitative study was conducted between 
November-December, 2013. Focus group discussions were conducted separately by feeding 
modality (i.e. breastfeeding or formula feeding) and took about four hours to complete. 
Individual interviews were each approximately 1 hour in length. Focus group discussions and 
individual interviews were conducted at KID-CRU, in Tygerberg Academic Hospital. All 
discussions and interviews were audio-recorded. 
 A total of 38 (breastfeeding (n = 15), formula feeding (n = 23)) women were invited to 
participate in the qualitative study, of these 8 refused to participate. Seven breastfeeding and 
eight formula feeding women participated in focus group discussions and twenty-three 
participated in the individual interviews (eleven of whom were breastfeeding). Among those 
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who participated in the individual interviews, three formula feeding and five breastfeeding 
women had participated in the focus group discussions. 
The sample of eight formula feeding and seven breastfeeding women who participated in 
focus group discussions was fairly adequate. Northcutt and McCoy, authors of the 
Interactive Qualitative Analysis methods used for the qualitative study suggest that focus 
group representation should include 12 to 20 participants (113) . The authors also comment 
that small focus groups are not a serious problem during identification of factors describing 
their experiences with a certain phenomenon under study but may only skew data when 
looking at relationships between the factors. In our study 23 women participated in the 
individual qualitative interviews where we looked at the relationships between the factors 
affecting their infant feeding experiences. 
Study design 
An Interactive Qualitative Analysis method was used, where HIV-infected women close to a 
phenomenon under study (infant feeding experiences) described, labelled their experiences, 
and articulated perceived relationships among their experiences to produce a system 
influence diagram (mental model) representing how the women understood their infant 
feeding experiences (113). The method uses Systems Theory (114) to conceptualize a 
phenomenon as comprising a system of factors and relationships among the factors. The 
factors in IQA research represent categories of meaning from a group sharing a common 
experience on an issue. To understand a system, the factors of the system and relationships 
among the factors are identified and described. Focus group discussions are used to identify 
the factors. The focus group participants are asked to silently reflect and write their 
experience, thoughts, beliefs and feelings on the issue under study (113). Relationships 
reflect participants’ perceptions of the association among the factors. 
Focus group discussions: Identification of system ‘factors’ 
To identify the factors associated with infant feeding practices, the focus group participants 
were given an opportunity to reflect on their infant feeding experiences and then express 
their thoughts and emotions involved. This assisted focus group participants in organising 
their thoughts into a manageable number of sets of textual references that have an 
underlying common meaning or theme. Participants documented their infant feeding 
experiences on note cards, one experience per card. Once completed, the cards were taped 
on a wall. The facilitator read aloud the contents of each card and guided participants in 
clarifying their understanding of the responses on each card to eliminate any ambiguity 
associated with the meanings of the words or phrases. The group had to reach consensus 
on the meaning of each card’s contents. The purpose was to arrive at a socially constructed, 
shared meaning of the contents of each card among focus group participants. Assisted by 
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facilitators, participants reviewed all the cards on the wall and clustered them into factors or 
common themes. When the majority of the cards were clustered, the facilitators helped 
participants to identify an appropriate label for each cluster. Any cards that were 
miscategorised were sorted into appropriate category.  
Open-ended individual qualitative interviews 
Individual interviews for breastfeeding women were guided by factors that emerged from the 
breastfeeding focus group discussion, and similarly for formula feeding women. The 
facilitator shared the focus group’s description of each factor with the individual woman and 
then engaged in a dialogue to explore the personal meaning, and life history experiences of 
the woman on the factor. 
During the individual interviews, participants were asked to describe the relationship 
between the factors identified in the focus group discussions. This was facilitated by asking 
the participant to speak about the three possible types of relationships between each pair of 
‘factors’ as follows: A influences B (A→B), B influences A (A←B), or no clear relationship 
(A<>B). In the interviews, this exercise was presented as follows: “Look at A and B, as you 
think about what you have said about these factors, do you see a direct connection between 
these two or some sort of influence between these two? Explain why you believe so or would 
you give an example from your own experiences, opinion, values or feelings with the 
relationship between A and B”. Exploring participants’ perceptions of relationships between 
‘factors’ enabled a deeper understanding of how they experienced infant feeding. 
Factor description and analysis 
Quotes gathered from index cards that were generated by focus group participants, 
transcripts of the focus group discussions and from the individual interview were used to 
develop composite descriptions to illustrate the range of meaning for each factor. This was 
supplemented by the individual interviews resulting in rich descriptions for each factor. 
A summary description of the factors describing HIV-infected women’s infant feeding 
experiences was generated separately for women who breast- and formula fed. The ‘System 
Influence Diagrams’ (SIDs) (113) served as graphical representations of relationships among 
factors affecting women’s experiences of infant feeding. The SIDs served as a basis for 
further thematic analysis of women’s experiences relative to understanding their decision 
between breast and formula feeding. 
Ethical aspects 
A verbal consent was obtained from all participants participating in the qualitative study. 
Participants were made aware that; they were free to express their thoughts without penalty, 
their identity was protected, and there were no reprisals due to their participation. The 
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qualitative study and verbal consent for participation in the qualitative study was approved by 
Stellenbosch University, Human Research ethics committee as an amendment of the main 
protocol. 
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Chapter 4 
Infant feeding practices and effects on infant growth and morbidity in PMTCT 
programs transitioning to “Option B+” in Western Cape, South Africa 
 
Abstract 
Introduction 
Despite the current recommendations for HIV-infected women to breastfeed with 
combination antiretroviral treatment, there are limited data on growth and morbidity of HIV-
exposed infants in normal practice settings. The objectives of this study were to describe 
infant feeding practices of HIV-infected women and compare to those of HIV-uninfected 
women and to determine the effect of predominant breastfeeding and predominant formula 
feeding on growth and morbidity of HIV-exposed infants, over a 12 months period.  
Methods 
We established a longitudinal cohort study of HIV-infected women and their infants, between 
July 2012 and December 2014. HIV-infected women had a choice between exclusive 
breastfeeding and subsidized formula feeding. The mother decided on feeding practice 
during her interactions with the public PMTCT program. Free formula milk for 6 months was 
available to all HIV-infected women whose initial choice was not to breastfeed. The 
cumulative probabilities of remaining predominantly breastfeeding were compared between 
HIV-infected and HIV-uninfected women using Kaplan-Meier estimation methods and log-
rank test. Infant growth rates were estimated and compared between feeding groups using 
linear mixed effects models. Infection-related hospitalizations were modelled as a binary 
outcome in a mixed effects logistic regression model. 
Results 
One hundred twenty-one HIV-exposed uninfected infants were included in the analysis. Of 
these, 50 (41%) were in the breastfeeding group and 71 (59%) were in the formula feeding 
group. The proportion of women who remained predominantly breastfeeding during follow-up 
was slightly lower among HIV-infected women than HIV-uninfected women (p = 0.0005). By 
about 4 months half of the HIV-infected women had switched to predominant formula 
feeding. After adjusting for women’s educational level and cART status, mean weight 
velocity z-scores (95% CI) of predominantly breastfed infants in the 2 to 4 age interval was -
0.70 (-1.31 to -0.09) lower than the mean of predominantly formula fed infants, p =0.024.  
Attained WAZ, LAZ and WLZ were similar between feeding groups at each study visit. There 
were 27 infection-related hospitalizations, 5 of these occurred among predominantly 
breastfed and 22 among predominantly formula fed infants. After adjusting for woman’s 
Stellenbosch University  https://scholar.sun.ac.za
44 
 
educational level, cART status, and infant age, the odds of infection-related hospitalizations 
among predominantly breastfed infants were 5% lower than of predominantly formula fed 
infants, odds ratio (OR) 0.95 (95% CI: 0.33 to 2.74).  
Conclusion 
Many women stop breastfeeding early, despite the recommendations favouring 
breastfeeding. Strategies to promote and sustain continued breastfeeding by women, to 
levels that would result in a significant impact on the health of their children are urgently 
needed. The strategies should be guided by women’s understanding of HIV transmission 
through breast milk, quality of counselling, stigma and constraints of economic realities 
affecting women’s feeding practices.  
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Introduction 
Since the discovery that HIV can be transmitted through breast milk more than 30 years ago 
(46-48), information has been accumulating to guide infant feeding guidelines for HIV-
infected women in low-resourced settings.  
In 2001, the WHO recommended formula feeding for HIV-infected women in low-resourced 
settings based on experiences from high-income countries (59). The drawbacks of the 
guidelines were that most HIV-infected women in low-resourced settings could not afford 
formula milk and formula feeding was also associated with increased risk of death from 
malnutrition and serious illnesses such as diarrhoea, respiratory and middle ear infections 
(115). The protective role of breastfeeding against infant morbidity, mortality and poor 
growth, especially in low-resourced settings is well established (1,70). However, there was 
also a substantial risk of HIV transmission to the infants through breast milk (116). The 
guidelines were therefore revised to further minimise the risk of HIV transmission based on 
studies showing that cART or prophylaxis given either to the mother or infant reduces the 
risk of HIV infection through breast milk (5,77). The WHO guidelines of 2010 and 2013 took 
into consideration provision of cART to the woman either for a recommended period or for 
life, respectively. The current guideline (WHO 2013), recommends triple-cART, irrespective 
of women’s CD4 count, which has to be maintained at least for the duration of breastfeeding 
or as lifelong treatment, also called “Option B+” (9). Countries that have successfully 
implemented these guidelines have reduced the numbers of HIV-infected children to <2%, 
resulting in a growing population of HIV-exposed uninfected infants. There is emerging 
evidence showing that HIV-exposure may also influence health outcomes of HIV-exposed 
uninfected infants (92, 93). There are many possible ways that could increase the risk for 
poor health outcomes of an HIV-exposed uninfected infant. The HIV-exposed foetus is 
exposed to maternal HIV and to antiretroviral drugs in-utero (94). Often HIV-exposed infants 
are exposed to other infectious agents, including Mycobacterium tuberculosis, than HIV-
unexposed infants and all these contribute in varying degrees to poorer health outcomes 
(95-97). HIV-exposed infants including uninfected infants are exposed to long courses of 
ARV drugs, and the effects of the drugs on HIV-exposed uninfected infants’ growth are not 
well established (93).  
The implementation of these guidelines has been a challenge in many low-resourced 
settings (12). Many factors, including practical, economic, social, psychological and cultural 
challenges have been associated with suboptimal infant feeding practises (88, 89). Poor 
counselling has been linked to these challenges (90). In addition, the risk of HIV 
transmission through breast milk has made infant feeding practices complex in the context of 
HIV (91).  
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The South African national PMTCT program adopted the WHO guidelines in 2010 (83). At 
the time, however, the South African national PMTCT guidelines promoted both exclusive 
breastfeeding and formula feeding. Healthcare authorities from the provinces supported 
different feeding options, with most choosing exclusive breastfeeding and a few supporting 
formula feeding. HIV-infected women in the Western Cape were provided free commercial 
formula milk, until the infant was 6 months old. Formula feeding had a high uptake (>70%) 
with relatively low rates of breastfeeding, in the province. Two years later, in 2012, the 
Western Cape PMTCT program transitioned from formula feeding to breastfeeding with 
cART. During the transitional period, women had an option to choose either exclusive 
breastfeeding or formula feeding. This unique transition scenario caused confusion for both 
healthcare providers who advised and for HIV-infected women who had to make a difficult 
choice. 
The feeding guidelines for HIV-infected women in low-resourced settings are primarily 
informed by studies conducted under ideal conditions. Most of these studies put much effort 
on controlling guidelines adherence of investigators and participants. The limitation of such 
studies is that the findings may not reflect what happens in real world settings, where HIV-
infected women are not closely monitored. Study findings from normal practice settings are 
likely to reflect what happens to a larger population of HIV-infected women and infants born 
to HIV-infected women, and are therefore likely to inform infant feeding policy and practice 
for HIV-infected women in low-resourced settings. Despite the current recommendations for 
providing lifelong cART and promoting breastfeeding among HIV-infected women, there are 
limited data on growth and morbidity of HIV-exposed uninfected infants in normal practice 
settings.  
The primary objectives of this study were to: a) describe infant feeding practices of HIV-
infected women, b) compare infant feeding practices of HIV-infected and HIV-uninfected 
(included in the Mother-Infant Health study) women, whose initial choice was to breastfeed, 
c) assess the effect of predominant breastfeeding and predominant formula feeding on 
attained growth, growth velocity and infection-related hospitalizations among HIV-exposed 
uninfected infants, over a 12 months period. The study was conducted during a time the 
Western Cape PMTCT program was transitioning to providing all women with lifelong cART 
and promoting breastfeeding.  
Methods 
Study design 
We performed a longitudinal cohort study of HIV-infected women and their exposed infants 
over a 12 months period. This was part of a larger study, the Mother-Infant Health Study that 
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was comparing infection-related hospitalizations among HIV-exposed uninfected (n = 94) 
and HIV-unexposed infants (n = 82). The main objective of the Mother Infant Health Study 
was the effect of HIV exposure on infection-related morbidity in the first 6 months of life 
(primary objective) and at 12 months (secondary objective). Infant feeding was a covariate, 
whereas, this study closely evaluated infant feeding practices for which the Mother Infant 
Health Study had no data. HIV-uninfected women (n = 81) were the comparative group in 
the Mother Infant Health Study and their breast feeding patterns were included in our study 
to contrast with those of the HIV-infected women. 
Study population and setting 
Women from four suburbs (from Kraaifontein midwife obstetric unit drainage area) with 
comparable low socioeconomic status, who gave birth between July 2012 and December 
2013 at Kraaifontein Midwife Obstetric Unit, a primary healthcare unit in an underserved 
community in Cape Town, were invited to participate in the study. Women could participate if 
they were at least 16 years of age and delivered at the obstetric unit. We evaluated HIV-
infected women who had been on AZT for ≥ 2 weeks or on cART for ≥ 6 weeks before 
delivery; women who were pregnant with more than 1 infant were excluded.  Infants of HIV-
infected women were enrolled if they had a birth weight of at least 2000g and a gestational 
age of 36 weeks or more. Mother-infant pairs were followed for 12 months post-delivery at 
KID-CRU, Tygeberg Academic hospital in Cape Town. Final follow-up was completed in 
December 2014.  
 
The protocol was approved by the Human Research Ethics Committee of Stellenbosch 
University. Participants were provided R100 (~US$10) at each follow-up visit to compensate 
for their time, as well as transportation reimbursement.  
Study measurements and procedures 
Baseline socio-demographic characteristics and clinical data were obtained by data 
abstraction from maternity case records and by interviewing the mother. Mother-infant pairs 
were followed-up at 2 weeks, 2, 4, 6, 9, and 12 months post-delivery.  At each visit, research 
staff administered an infant feeding questionnaire based on a WHO standardized instrument 
(104), which inquired about feeding practices during the previous 24 hours and during the 
prior week. Infant weight and length were measured using a digital scale and a length board, 
respectively. Interviews were conducted in Xhosa, Afrikaans or English. 
 
HIV testing of infants was done at 2 weeks and 6 months using a DNA polymerase-chain-
reaction assay (PCR) and at 12 months using an enzyme-linked immunosorbent assay 
(ELISA). A DNA PCR confirmatory test was performed on infants with reactive ELISA test 
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results. All testing was performed at the National Health Laboratory Services at Tygerberg 
Hospital. 
 
HIV-infected women had a choice between exclusive breastfeeding and subsidized formula 
feeding. The mother decided on feeding practice during her interactions with the public 
program. We accepted the mother’s choice and recruited into the appropriate feeding group 
and supported mother’s adherence to her infant feeding practice. Free formula milk for 6 
months was available to all HIV-infected women whose initial choice was not to breastfeed. 
Antiretroviral treatment was given to the mother or the infant, depending on mother’s clinical 
indications. 
Clinical definitions 
Predominant breastfeeding was defined as the infant receiving mainly breast milk as well as 
other liquid or solid foods, but not formula milk. Predominant formula feeding was defined as 
the infant receiving mainly formula milk and other liquid or solid based foods, but not breast 
milk (104). If infants were receiving both formula and breast milk during the same period, 
they were classified as receiving mixed feeding.  
 
We searched the national health information service system (Clinicom) to identify any 
hospitalizations that occurred among enrolled infants. Two study investigators (including the 
principal investigator) abstracted information on the admissions. Two paediatricians who 
were unaware of the feeding mode of the infants reviewed the abstracted information and 
independently classified the hospitalizations as resulting from lower respiratory tract 
infections (including pneumonia, bronchiolitis, or tuberculosis), and diarrheal disease (acute, 
persistent, or dysenteric). Cases of discrepant classification were resolved by discussion.  
Sample size and power justification 
A total sample size of 188 HIV-exposed uninfected infants was required to reject the null 
hypothesis that WAZ- scores at 6 months of age, were similar between predominantly 
breastfed (n = 94) and predominantly formula fed (n = 94), with probability (power) of 0.80. 
This was derived from the mean WAZ-scores (SD) of 0.61 (1.17) and 0.17 (0.95) in 
predominantly breastfed and predominantly formula fed infants, respectively, observed in 
two South African studies, (111,112). All HIV-uninfected women in the Mother Infant Health 
Study (a convenience sample of n = 81) who met the eligibility criteria and had at least one 
follow-up visit were included in the analysis. 
Statistical methods 
Only HIV-exposed infants who remained HIV-1 negative by PCR or ELISA test and had at 
least one follow-up visit were included in analysis. Two infants who became HIV-infected 
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were censored at the time point they were confirmed HIV-positive. One was confirmed HIV-
positive at 2 weeks after birth and was breastfeeding at baseline and the other was 
confirmed at 2 months and was formula feeding. 
Infants who were lost to follow-up were censored at the last study visit. Similarly, infants who 
were neither breastfeeding nor formula feeding were included in analysis only at visits they 
were predominantly breastfeeding or formula feeding. Some women switched feeding 
modality between study visits; the infant was therefore assigned to the feeding practice 
group which the woman reported at that visit. A t-testing was used to compare the 
distribution of baseline continuous variables. Categorical variables were compared between 
the two feeding groups using Pearson’s chi-square or Fisher’s exact test. The cumulative 
probabilities of remaining predominantly breastfeeding were compared between HIV-infected 
and HIV-uninfected women using Kaplan-Meier estimation methods and log-rank test.  
The 2006 World Health Organization growth standards were used to calculate attained WAZ, 
LAZ and WLZ at each study visit (105). Similarly a macro based on the 2009 WHO growth 
velocity standards was used to compute WVZ and LVZ (105) that represent growth rates 
over a period of time. Weight and length were standardized in reference to the normal 
growth rate in the specific age period. Mean WAZ, LAZ and WLZ were calculated for infants 
in each feeding group for each study visit. Mean WVZ and LVZ were estimated for three 
independent time intervals and were compared between feeding groups using t-test. The 
differences in mean WVZ and LVZ between predominantly breastfed and predominantly 
formula fed infants were estimated using multiple linear regression. Predominantly breastfed 
and formula fed infants were compared for the infectious-related hospitalizations in the first 
year of life, conditioned on mother’s levels of education, cART status, and infant age in 
multivariate analysis. All socio-demographic, maternal and infant clinical characteristics were 
evaluated for possible confounding in univariate analyses. However, as this was a small 
study, which limited the number of variables to include in the multivariate analyses, priority 
was given to controlling for variables found in the literature to be important in influencing 
infant growth and infectious morbidity (117,118). The number of infection-related 
hospitalizations events further limited the number of covariates to include in the model. The 
response (infection-related hospitalizations) was binary valued (yes or no) at each follow-up 
visit. A generalized linear mixed effects logistic regression model was performed, assuming 
an unstructured covariance structure and allowing for within-child clustering. Infants who 
were hospitalized and had no information on their feeding practice at the time of 
hospitalization, because of a missed study visit were assigned the feeding group the mother 
reported adhering at the previous study visit.   
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Results 
One hundred eighty-five HIV-exposed infants were enrolled, of these 121 were HIV 
uninfected and had at least one-follow-up visit and were included in the analysis; 50 (41%) 
were breastfeeding and 71 (59%) were formula feeding at baseline. Figure 4.1 displays the 
flow of participants and feeding practices at study visit.  
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Figure 4.1 Flow of study participants and feeding practices at study visit 
*LTFU – Lost to follow-up 
           121 HIV-exposed uninfected infants with at least one follow-up  
2 weeks: 49 mother-infant pairs 
  41 breastfeeding 
    7 formula feeding 
    1 mixed feeding 
 
50 intended to breastfeed  71 intended to formula feed 
2 months: 41 mother-infant 
pairs 
32 breastfeeding 
  9 formula feeding 
9 formula feeding 
8 LTFU* 
  
4 months: 39 mother-infant pairs 
19 breastfeeding 
19 formula feeding 
  1 mixed feeding 
  
2 LTFU 
  
6 months: 38 mother-infant pairs 
10 breastfeeding 
24 formula feeding 
   4 mixed feeding 
 
 2 LTFU, 1 missed the visit 
9 months: 31 mother-infant pairs 
  8 breastfeeding 
22 formula feeding 
  1 mixed feeding 
5 LTFU 
2 missed the visit 
1 neither breastfeeding nor formula feeding 
12 months: 28 mother-infant 
pairs 
  4 breastfeeding 
23 formula feeding 
  1 mixed feeding 
 
5 LTFU 
1 neither breastfeeding nor formula feeding 
2 weeks: 67 mother-infant pairs 
65 formula feeding  
  1 breastfeeding 
  1 mixed feeding 
1 missed the visit 
  
2 months: 64 mother-infant pairs 
63 formula feeding 
  1 mixed feeding 
2 LTFU 
1 HIV-infected 
2 missed the visit 
1 mixed feeding  
4 months: 58 mother-infant pairs 
57 formula feeding 
  1 breastfeeding 
5 LTFU 
5 missed the visit 
6 months: 52 mother-infant pairs 
49 formula feeding 
1 breastfeeding 
2 mixed feeding 
6 LTFU 
5 missed the visit 
9 months: 50 mother-infant pairs 
49 formula feeding 
  1 breastfeeding 
 
2 LTFU 
4 missed the visit 
12 months: 45 mother-infant pairs 
41 formula feeding 
  1 breastfeeding 
  3 mixed feeding 
8 LTFU 
2 neither breastfeeding nor formula feeding  
1 HIV-infected 
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Baseline socio-demographic and clinical characteristics were similar between the groups, 
except that breastfeeding women tended to be less likely on cART than formula feeding 
women (44% versus 61%, p = 0.07) (Table 4.1). Almost all (98%) HIV-infected women were 
in WHO HIV stage 1 or 2 (data not shown). Mean infant birth weight was similar between the 
feeding groups. Almost all infants (99%) were started on NVP at birth. 
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Table 4.1 Characteristics of HIV-infected women, HIV-exposed uninfected infants and HIV-uninfected 
women, stratified by woman’s feeding practice at enrolment 
  
HIV-infected women  
 
HIV-uninfected women 
 
Characteristic 
 
Breastfeeding  
N=50 (41%) 
 
Formula Feeding  
N=71 (59%) 
 
p-value* 
 
Breastfeeding 
N=81 
 
Women 
    
Age, yrs (mean, ± SD)  27.86 ± 5.82 27.98 ± 6.32 0.91 26.13 ±5.25 
Racial group    0.71  
Black African    44 (88) 64 (90)  73 (90) 
Coloured  6 (12) 7 (10)  8 (10) 
     
Marital status   0.80  
Never married  34 (68)  50 (70)  52 (64) 
Married  14 (28) 17 (24)  28 (35) 
Widowed/divorced 2 (4) 4 (6)  1 (1) 
Educational level   1.00  
Primary  3 (8) 4 (6)  3 (4) 
Secondary  47 (92) 67 (94)  78 (96) 
     
†ART                    ------ 
On cART  22 (46) 43 (61) 0.07  
 
 
ART during 
pregnancy/delivery  
 
N=26 
26 (54) 
 
N=27 
27 (39) 
 
 
0.80 
 
 
     
Smoking in pregnancy N=49 N=68   
 6 (12) 9 (13) 0.87 3 (4) 
     
Alcohol use  in pregnancy        N=48 N=68   
 5 (10) 12 (18) 0.28 9 (11) 
     
Piped water available  N=50 N=70   
 46 (92) 69 (99)  0.16 73 (90) 
     
Flush toilet in home  N=50 N=70   
 49 (98) 69 (99) 1.00 80 (99) 
     
Working refrigerator in home N=50 N=70 0.39  
 35 (70) 53 (76)  63 (78) 
Infants     
Female 27 (54) 34 (48) 0.51 45 (56) 
Gestational age at delivery, 
wks, mean ± SD 
38.4 ± 1.8 38.7 ± 1.8 0.35 39.2 ± 1.5 
     
Birthweight (grams), mean ± 
SD 
3090 ± 395 3133 ± 401 0.55 3236 ± 441 
     
Birth length (cm), mean ± SD 49.1 ± 2.8 48.0 ± 4.3 0.11 49.7 ± 3.7 
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*p-values based on chi-square test or fishers exact test for categorical variables, and t-test for 
continuous variables; †Two HIV-infected women in the breastfeeding group and one women in the 
formula feeding group had missing information on ART              
After 1 year of follow-up, 73 of 121 (60%) infants completed the study. The follow-up rate 
was 55% (28 of 51) in the breastfeeding group and 63% (45 of 71) in the formula feeding 
group. About 92% (12 of 13) and 87% (45 of 52) predominantly breastfeeding and formula 
feeding women reported their rate of adherence to cART as very good or excellent at 4 
months post-delivery. At 6 months, 88% (74 of 84) had received required immunizations. 
Twelve HIV-infected women who mixed-fed at some point (giving their infants breast- and 
formula milk at the same time) was not an anticipated group and were not included in the 
initial objectives for evaluation. The women subsequently switched to either predominant 
breastfeeding or formula feeding, of these 5 were in the breastfeeding group at enrolment. 
Among HIV-infected women, the median (range) duration of exclusive breastfeeding was 1.9 
(0.4 to 12) months and that of exclusive formula feeding was 4.0 (0.5 to 12) months, the 
median (range) duration of predominant breastfeeding was 2.0 (0.43 to 12.06) months and 
that of predominant formula feeding was 8.67 (0.46 to 12.75) months and the median 
(range) duration of mixed feeding was 4.04 (2.30 to 5.78) months. Among HIV-uninfected 
women, the median (range) duration of exclusive breastfeeding was 0.84 (0.46 to 6.5) 
months and the median (range) duration of predominant breastfeeding was 2.07 (0.46 to 
12.42). Figure 4.2 displays the proportion of HIV- infected and uninfected women who 
remained predominantly breastfeeding during follow-up. The proportion of women who 
remained predominantly breastfeeding was slightly lower among HIV-infected women than 
HIV-uninfected women (p = 0.0005). These differences were seen from about 2 weeks, and 
persisted throughout follow-up. By about 4 months half of the HIV-infected breastfeeding 
women had switched to predominant formula feeding. 
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Figure 4.2 Proportion of HIV-infected and HIV-uninfected women who initially chose breastfeeding 
and remained predominantly breastfeeding during follow-up (logrank test p = 0.0005). 
Infant growth 
Figure 4.3 and Table 4.2 displays the average infant WAZ, LAZ, WLZ and corresponding 
95% CI by feeding practice at study visit. Infants in all groups experienced exponential 
weight gain, with rapid increase in weight from birth to about 6 months. Attained growth was 
similar between feeding groups at each study visit. One predominantly formula fed infant had 
WLZ < -2 at 12 months. 
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Figure 4.3  Mean and 95% confidence intervals for  weight-for-age, length-for-age, weight-for-length z-
scores of HIV- exposed uninfected infants by feeding practice (        breastfeeding,        formula 
feeding) 
Mixed feeding group, was not included because few women were mixed feeding at each study visit, 
making the 95% CI too wide. 
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Table 4.2 Mean (95% CI) WAZ, LAZ, WLZ of HIV-exposed uninfected infants by feeding practise 
 
Age 
(months) 
Predominant breastfeeding  Predominant formula feeding 
  
WAZ LAZ WLZ WAZ LAZ WLZ 
      
At Birth -0.46 
(-0.70 to -.22) 
-0.21 
(-0.62 to 0.20) 
-0.51 
(-0.93 to-0.09) 
-0.37 
(-0.58 to -0.16) 
-0.82 
(-1.36 to -0.29) 
-0.14 
(-0.61 to .33) 
0.5  -0.41 
(-0.72 to -0.10) 
-1.24 
(-1.60 to -0.88) 
0.70 
(0.42 to 0.98) 
-0.47 
(-0.67 to -.27) 
-1.25 
(-1.47 to -1.04) 
0.62 
(0.38 to 0.85) 
2 -0.25 
(-.67 to 0.18) 
-0.95 
(-1.34 to -0.56) 
0.93 
(0.54 to 1.32) 
-0.28 
(-0.51 to -0.04) 
-1.23 
(-1.48 to -0.99) 
1.24 
(0.98 to 1.50) 
4  -0.17 
(-0.80 to 0.45) 
-0.94 
(-1.40 to -0.47) 
0.75 
(0.13 to 1.36) 
0.10 
(-0.16 to 0.35) 
-0.88 
(-1.16 to -0.60) 
1.08 
(0.79 to 1.38) 
6  0.10 
(-1.18 to 1.37) 
-0.94 
(-1.70 to -0.18) 
0.94 
(-0.33 to 2.21) 
0.26 
(0.00 to 0.52) 
-0.60 
(-.81 to -0.38) 
0.90 
(0.61 to 1.18) 
9  0.43 
(-1.15 to 2.01) 
-0.81 
(-1.65 to 0.04) 
1.17 
(-0.34 to 2.68) 
0.29 
(-0.01 to 0.58) 
-0.45 
(-0.66 to -0.25) 
0.76 
(0.45 to 1.08) 
12  -0.16 
(-2.06 to 1.75) 
-1.11 
(-2.78 to 0.56) 
0.53 
(-1.11 to 2.16) 
0.30 
(-.04 to 0.64) 
-0.68 
(-0.93 to -0.42) 
0.81 
(0.45 to 1.17) 
 
Overall, WVZ ranged from -4.88 to 2.93 in interval 1, -2.03 to 3.10 in interval 2 and -3.50 to 
5.81 in interval 3. LVZ ranged from -6.24 to 10.87 in interval 1, -4.56 to 5.08 in interval 2, and 
-3.09 to 6.79 in the third interval. Mean WVZ differed (p = 0.02) between the feeding groups 
in the second interval but not in the first and third (Table 4.3). The mean LVZ of 
predominantly breastfed infants tended to be lower than that of predominantly formula fed 
infants in the second interval (p = 0.08) (Table 4.3). After adjusting for women’s educational 
level and cART status, mean WVZ (95% CI) of predominantly breastfed infants was -0.70 (-
1.31 to -0.09) lower than that of predominantly formula fed infants in the second interval, p = 
0.024 but not in first interval with a difference of 0.11 (-0.38 to 0.60), p = 0.66 and in the third 
interval with a difference of -0.06 (-1.11 to 0.99), p = 0.91. Similarly, the difference in mean 
LVZ (95% CI) between predominantly breastfed and predominantly formula fed infants were 
insignificant with a difference of -0.05 (-1.23 to 1.13), p = 0.94, in the first interval, -0.74 (-
1.62 to 0.13), p = 0.10, in the second interval and -0.25 (-1.63 to 1.13), p = 0.72, in the third 
interval.  
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Table 4.3 Mean velocity Z-scores by age interval and infant feeding practise 
*t-test p values for group comparisons 
Infection-related hospitalizations 
There were 27 infection-related hospitalizations, overall. Five of these occurred among 
predominantly breastfed infants: (3 infants were hospitalized once and 1 was hospitalized 
twice), and 22 occurred among predominantly formula fed infants (15 infants were 
hospitalized once, 2 were hospitalized twice, and 1 was hospitalized thrice). Most of the 
hospitalizations were due to lower respiratory tract infections and diarrhoeal disease. Of the 
20 lower respiratory tract infections, 3 were among predominantly breastfed infants. There 
were 10 diarrhoeal diseases among predominantly formula fed infants. No infections were 
recorded during a time infants were mixed fed. Predominantly breastfed infants were 
exposed to breast milk for a total of 168.31 months. Predominantly formula fed infants were 
exposed to formula milk for a total of 828.45 months and mixed fed infants for 8.08 months. 
The unadjusted incidence rate of infected-related hospitalizations was 30 per 1000 months 
of predominant breastfeeding and 27 per 1000 months of predominant formula feeding. The 
unadjusted odds of infection-related hospitalizations among predominantly breastfed 
children were 27% lower compared to the odds of predominantly formula fed infants, OR 
0.73 (95% CI: 0.26 to 1.99), p = 0.53. After adjusting for woman’s educational level, cART 
status, and infant age, the OR was 0.95 (95% CI: 0.33 to 2.74), p = 0.92. 
The evidence was therefore insufficient to reject the null hypotheses that HIV-exposed 
uninfected infants on predominantly breastfeeding had similar growth z-scores and infectious 
morbidity to predominantly formula fed infants. 
Discussion 
We found that, despite, women being on cART or their infants on ARV prophylaxis and the 
recommendations favouring breastfeeding, few HIV-infected women chose this option, and 
among those who did, many switched to formula feeding early. More HIV-infected women 
 Predominantly breastfed 
Mean (95% CI) 
n Predominantly formula fed 
Mean (95% CI) 
n p* 
WVZ      
  Interval 1 (0 – 2) months -0.09 (-0.56 to 0.38) 31 -0.24 (-0.51 to 0.04) 71 0.57 
  Interval 2 (2 – 4) months -0.22 (-0.77 to 0.33) 18 0.49 (0.21 to 0.77) 67 0.02 
  Interval 3 (4 – 6) months  1.00 (-0.21 to  2.22) 11 1.03 (0.63 to 1.42) 63 0.96 
LVZ      
  Interval 1 (0 – 2) months -1.59 (-2.32 to -0.85) 31 -1.57 (-2.29 to -0.84) 67 0.97 
  Interval 2 (2 – 4) months -0.61 (-1.09 to -0.14) 18 0.15 (-0.28 to 0.58) 67 0.08 
  Interval 3 (4 – 6) months     1.22 (0.13 to 2.32) 11 1.51 (0 .99 to 2.04) 68 0.67 
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switched to predominant formula feeding than HIV-uninfected women; however, the 
proportion of HIV-uninfected women who switched to predominant formula feeding was 
relatively high. Doherty et al., 2012 reported similar findings in South Africa, where 20% and 
40% of HIV-uninfected and HIV-infected women had stopped breastfeeding at 3 months, 
respectively (119). There seem to be diverse experiences in different settings. In Botswana 
for example, where formula feeding policy was supported for about 1.5 decades, there is 
supporting evidence indicating acceptability of breastfeeding by HIV-infected women (4). 
The reasons why women in our study stopped breastfeeding are not clear. In a separate 
qualitative evaluation of a sub-set of these subjects (described in Chapter 5) we found that 
women were confused and constantly feared that their child may contract HIV through breast 
milk because of conflicting messages they received from healthcare providers, possibly 
explaining why some women stopped breastfeeding. These findings suggest that all women, 
irrespective of their HIV status need to be educated that breastfeeding is the feeding of 
choice in this setting. HIV-infected women should be educated that cART and adherence to 
treatment would make breastfeeding safe. Adopting feasible strategies such as the home 
visit by community health workers model suggested by Tomlinson et al., 2014 may improve 
adherence to prolonged breastfeeding (120). A few women were mixed feeding at some 
point, placing their infants at risk for HIV infection (121).  
Predominantly breastfed infants had poorer weight velocity compared to predominantly 
formula fed infants in the 2 to 4 months age interval. The higher caloric density due to 
micronutrient and macronutrient content of formula milk and adequate formula milk supplies 
may have contributed to better growth velocity of predominantly formula fed infants. McGrath 
et al., 2012 attributed caloric density of formula milk to the slower decline in length growth 
among formula fed infants compared to breastfed infants (122).  It is also plausible that the 
short duration of exclusive breastfeeding may have contributed to poorer weight velocity of 
predominantly breastfed infants. About 60% (3 of 5) of the infection-related hospitalizations 
among predominantly breastfed infants occurred during the 2 to 4 months age interval and 
this coincided with the time most infants were started on other liquids and solid based foods 
(median duration of exclusive breastfeeding was 1.9 months). These findings suggest that 
infants may be vulnerable during the age 2 to 4 months as they are started on other foods 
that may be contaminated and subsequently increasing their exposure to infectious morbidity 
that may result in suboptimal growth. Supporting findings were also reported in other 
settings, for example in Malawi where early weaning was significantly associated with 
reduced weight velocity and increased morbidity (123). A randomized trial in Zambia 
reported a significant decrease in WAZ scores among HIV-exposed uninfected infants who 
stopped breastfeeding at 4 months (3). Our findings differed with those of Kindra and 
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colleagues who found significant weight gain among breastfed infants compared to formula 
fed infants (112). High rate of exclusive breastfeeding, prolonged duration of breastfeeding 
and additional health interventions may have contributed to better weight gain among 
breastfed infants in that study (112). The benefits of breastfeeding are known to be 
influenced by the duration and frequency of breastfeeding. Our findings highlight the 
importance of monitoring breastfeeding practices of HIV-infected women and growth of their 
infants, especially during the first 12 months of life. 
Not surprisingly infection-related hospitalizations tended to be fewer among predominantly 
breastfed infants compared to predominantly formula fed infants.  However, these findings 
were not statistically significant. There were few infection-related hospitalizations in our 
study overall, the duration of exclusive breastfeeding was short and the study sample was 
small; these are likely to explain part of the minimal protective effect of breastfeeding against 
common infections found in our study. The subsequent switch from breastfeeding to formula 
feeding by women made it harder to draw conclusions on the role of breastfeeding for HIV-
exposed infants in primary healthcare settings. Our growth velocity results need to be 
interpreted with caution because of the small sample sizes, only infants who attended both 
study visits in question for a specific age interval were included in the analysis for this 
outcome. Although our study showed no effect of breastfeeding in preventing infections, 
studies conducted in controlled settings, demonstrated a protective effect. 
Our study described a unique transition of a dual infant feeding system and showed 
confusion caused among healthcare providers who had to advise and HIV-infected women 
who had to make a difficult choice. Subsequently, HIV-infected women who chose to 
breastfeed switched to formula feeding early and the overall effect of predominant 
breastfeeding on reducing infectious morbidity was minimal and insignificant. These factors 
distinguish this study from prior studies.  
Our study had several limitations. The study had challenges of inadequate enrolment and 
high early attrition rate that was not expected. In addition, few HIV-infected women chose 
the breastfeeding option. Only 98% of the enrolment target was reached (184 of a targeted 
188 HIV-infected women and their infants; breastfeeding group (n = 80), formula feeding 
group (n = 104)) following extension of the enrolment from 9 to 18 months. Financial 
constraints limited further extension of enrolment period. Of the 184 HIV-infected women 
and their exposed infants, only 121 (breastfeeding (n = 50), formula feeding (n = 71)) with at 
least one follow-up visit were included in the analysis. The study team attempted to increase 
participants’ attendance of study visits. Strategies included considering participants’ personal 
schedules when setting study appointments, offering free doctor consultations, appropriate 
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referral to specialized clinics for infants who required special care, and remuneration of R100 
(~US$10) at each follow-up visit to compensate for their time. This marked deviation in 
allocation of groups could have significantly reduced the power of the study to find any 
differences between predominantly breastfed and formula fed infants should there have 
been any true differences in infant growth and risk for infectious morbidity. The small sample 
size due to high attrition rate reduces our confidence to draw any definite conclusions from 
this study for differences in infant growth and risk of infectious morbidity between 
predominantly breastfed and formula fed HIV-exposed uninfected infants. Although we have 
no obvious reason that the infant growth rate and rate of infection-related hospitalization 
observed in the cohort that continued in the study would have been different from infants 
who did not continue with the study, attrition bias cannot be ruled out. We may not have 
found important clinical difference in infectious morbidity between breastfed and formula fed 
infants because the analysis focused on severe infections requiring hospitalizations. It is 
plausible that any pattern may have emerged should less severe infections at sick clinic 
visits had been included. Furthermore, we may not have found important clinical differences 
in infectious morbidity between breastfed and formula-fed infants due to exclusion of the 
infants at higher (infants <2000g and <36 weeks gestation at birth). This was done with 
intent to determine whether there is evidence of a difference for infant feeding practices 
other than other factors that determine risk for postnatal growth failure and infectious 
morbidity. We acknowledge that there is a potential for unmeasured and residual 
confounding because the study could not conducted in a randomized fashion, due to ethical 
implications of randomly assigning feeding behaviour. Infant feeding practices could have 
changed between follow-up visits, and the study may not have been able to capture these 
changes given the dynamics and complexity of infants feeding practices. Poor adherence to 
breast feeding was the most important unanticipated observation. 
 
The primary objectives of this study were to: a) describe infant feeding practices of HIV-
infected women, b) compare breastfeeding feeding patterns of HIV-infected and HIV-
uninfected women,  c) assess the effect of predominant breastfeeding and formula feeding 
on attained growth, growth velocity and infectious morbidity among HIV-exposed uninfected 
infants, over a 12 months period. In conclusion, many women stop breastfeeding early, 
despite the recommendations favouring breastfeeding. The Western Cape PMTCT program 
urgently needs strategies that promote and sustain continued breastfeeding by women, to 
levels that would result in a significant impact on the health of their children. The strategies 
should be guided by social and contextual factors affecting women’s feeding practices. 
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Chapter 5 
An interactive qualitative analysis on HIV-infected mother’s decisions between 
breast- and formula feeding in South Africa – Information, fears, family and friends 
 
Abstract 
Introduction  
As prevention of mother-to-child HIV transmission programs transition to universal lifelong 
combination antiretroviral treatment, breastfeeding is becoming more common than formula 
feeding, in South Africa. The aim of this sub-study was to explore HIV-infected women’s 
experiences and perceptions on breastfeeding and formula feeding. 
Methods 
Two separate focus group discussions of, a) breastfeeding- (n = 7) and b) formula feeding 
HIV-infected women (n =8) were conducted in November-December 2013 at Children’s 
infectious diseases clinical research unit, in Tygerberg academic hospital. Women reflected 
and wrote words describing their infant feeding experiences. Based on focus group 
responses, we conducted in-depth individual interviews (n = 23) to explore the personal 
meaning women attached to their feeding experiences. Data were analysed through 
interactive qualitative analysis. 
Results 
Study findings revealed two main themes. Theme one consisted of multiple (often competing 
or contradictory) influences that persisted beyond initiating either choice. The influences 
pushed and pulled women towards both feeding options. Theme two described three main 
interacting processes influencing women’s decision to either breast- or formula feed; 
information loops and incremental exposure to “feeding advice”, fear of making the “wrong” 
choice for their infant, and expectations, demands and responses from family and friends. 
These processes continued after the women had made a particular feeding choice. There 
were continual pressures which may explain some women’s periodic switching between 
breast- and formula feeding. 
Conclusion 
In conclusion, HIV-infected women were confused because of conflicting information they 
received from healthcare providers. There is an urgent need to engage and reorient HIV-
infected women, their families, the community and healthcare providers, about the rationale, 
and reasons for changes in infant feeding guidelines. Infant feeding guidelines for HIV-
infected women should integrate considerations of contextual and social issues affecting 
women’s infant feeding practices. 
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Introduction 
In 2013, there were about 3.6 million children younger than 15 years of age living with HIV, 
globally (124). Most (91%) of HIV-infected children live in sub-Saharan Africa. Approximately 
266 000 infants below 2 months of age were HIV exposed in South Africa in 2011, and about 
4 800 (2.8%) of these were HIV-infected (125). In 2013 approximately 10 000 new infections 
were estimated for children younger than 14 years of age in South Africa (126).  
Infant feeding in low-resourced settings with high HIV prevalence is a public health concern 
due to the risk of vertical transmission of HIV, especially in settings where breastfeeding is a 
social norm. Infant feeding guidelines are rapidly evolving to find the most appropriate infant 
feeding option for HIV-infected women in these settings. The revised WHO infant feeding 
guidelines recommend HIV-infected pregnant women receive cART, until at least one week 
after cessation of breastfeeding or after delivery when formula feeding (8,9). HIV-exposed 
infants on breast milk are recommended to receive once-daily NVP prophylaxis until they are 
fully weaned. Formula-fed infants should receive 4-6 weeks of daily NVP or twice-daily AZT.  
As PMTCT programs transition towards universal lifelong cART and promoting breastfeeding 
for HIV-infected women, we hypothesized that rates of breastfeeding would increase and 
formula feeding would decrease for HIV-infected women in the Western Cape Province of 
South Africa. Research efforts on infant feeding for HIV-exposed infants have mainly 
focused on medical and nutritional outcomes (11,127). Subsequently, much attention has 
been given on the clinical outcomes in development and implementation of infant feeding 
guidelines, while social and contextual factors have largely been neglected; consequently 
underestimated in the dynamic of infant feeding behaviours (13). Failure to understand 
social and contextual factors affecting women’s infant feeding practices could therefore 
compromise uptake of recommended infant feeding options. 
The aim of the qualitative study was to explore HIV-infected women’s experiences and 
perceptions on breastfeeding and formula feeding. The qualitative study was conducted 
about 2 years after the Western Cape PMTCT program started transitioning to providing all 
women with lifelong cART and promoting breastfeeding. Healthcare providers received 
within departmental training on counselling HIV-infected women on the importance of 
breastfeeding. The study compared the feeding experiences of breastfeeding and formula 
feeding HIV-infected women. 
Methods 
Participants 
A sub-sample of HIV-infected women participating in the longitudinal Mother-Infant Health 
cohort study was invited to participate in a breastfeeding and formula feeding focus group 
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discussion and individual qualitative interviews. HIV-infected women who were followed-up 
for at least 6 months post-delivery in the longitudinal cohort were eligible to participate in the 
qualitative study. Study participation was not restricted by women’s language. The women 
were contacted by telephone and invited to participate. The aim of the qualitative study was 
to explore HIV-infected women’s experiences and perceptions on breastfeeding and formula 
feeding during a time the Western Cape PMTCT program was transitioning to providing all 
HIV-infected women with lifelong cART and promoting breastfeeding. The sub-study was 
conducted between November-December, 2013.  
Focus group discussions were conducted separately by feeding modality (i.e. breastfeeding 
or formula feeding) and took about four hours to complete. Individual interviews were each 
approximately 1 hour in length. Focus group discussions and individual interviews were 
conducted at KID-CRU, in Tygerberg Academic Hospital. All discussions and interviews 
were audio-recorded. Verbal consent to participate in the sub-study was obtained. 
Sample 
A total of 38 (breastfeeding (n = 15), formula feeding (n = 23)) women were invited to 
participate in the qualitative study, of these 8 refused to participate. Seven breastfeeding and 
eight formula feeding women participated in focus group discussions and twenty-three 
participated in the individual interviews (eleven of whom were breastfeeding). Among those 
who participated in the individual interviews, three formula feeding and five breastfeeding 
women had participated in the focus group discussions. Sample sizes for the focus group 
and individual interviews were adequate to identify factors associated with infant feeding 
practices and relationships among the factors, respectively (113). Northcutt and McCoy, 
(2004), authors of the Interactive Qualitative Analysis methods used for the qualitative study 
suggest that focus group representation should include 12 to 20 participants (113). The 
authors also comment that small focus groups are not a serious problem during identification 
of factors describing their experiences with a certain phenomenon under study but may only 
skew data when looking at relationships between the factors. Overall, the mean (SD) age of 
infants of women who participated was 10 (3.11) months. See Table 5.1 for baseline 
characteristics of participants. 
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Table 5.1 Baseline Characteristics of women who participated 
 Focus group Individual interviews 
Characteristic Breastfeeding Formula feeding Breastfeeding Formula feeding 
N 7 8 11 12 
Age in years, mean (SD) 30.7 (3.3) 27.9 (4.6) 29.6 (4.5) 27.3 (6.3) 
 
Marital status 
  Never married 
  Married  
Widowed/separated 
 
 
2 
3 
2 
 
 
8 
--- 
--- 
 
 
5 
5 
1 
 
 
10 
2 
---- 
 
Race 
  Black African 
  Mixed race 
 
 
6 
1 
 
 
7 
1 
 
 
9 
2 
 
 
11 
1 
 
Educational level 
 Primary 
 Secondary 
 
 
1 
6 
 
 
1 
7 
 
 
1 
10 
 
 
--- 
12 
 
Language 
  Xhosa 
  Afrikaans 
  Other African 
 
 
4 
1 
2 
 
 
5 
2 
1 
 
 
8 
2 
1 
 
 
8 
1 
3 
 
Disclosed HIV status 
  Yes 
 
 
7 
 
 
7 
 
 
10 
 
 
11 
 
Disclosed HIV status to* 
  Husband/partner 
  Maternal parents 
  Paternal parents 
  Friends 
  Other 
 
 
4 
1 
--- 
1 
1 
 
 
3 
2 
1 
--- 
4 
 
 
7 
2 
1 
--- 
2 
 
 
8 
4 
1 
2 
3 
     
*Some women had disclosed their HIV status to more than one person 
Study design: Interactive Qualitative Analysis 
We used an IQA method. HIV-infected women close to a phenomenon under study (infant 
feeding experiences in this case) described, labelled their experiences. Women articulated 
perceived relationships among their experiences to produce a system influence diagram 
(mental model) representing how the women understood their infant feeding experiences 
(113). The method uses Systems Theory (114) to conceptualize a phenomenon as 
comprising a system of factors and relationships among the factors. The factors in IQA 
research represent categories of meaning from a group sharing a common experience on an 
issue. To understand a system, the factors of the system and relationships among the 
factors are identified and described. Focus group discussions are used to identify the 
factors. The focus group participants are asked to silently reflect and write their experiences, 
thoughts, beliefs and feelings on the issue under study (113). Relationships reflect 
participants’ perceptions of the relationship among the factors. 
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Focus group discussion 
Group discussions were facilitated by a trained counsellor and three research trainees 
(including myself). The discussions were conducted in Xhosa, English translations were 
made for non-Xhosa speaking women and research trainees. The counsellor explained the 
purpose of the study and the activities the participants would perform during the discussions. 
The research questions were presented as issue statements. The issue statement for 
breastfeeding women was: “Tell me your experiences with breastfeeding your baby. Reflect 
on all thoughts you had concerning the feeding experiences.” The issue statement for 
formula feeding women was: “Tell me your experiences with formula feeding your baby. 
Reflect on all thoughts you had concerning the feeding experiences.” 
HIV-infected women openly expressed their experiences, thoughts and emotions that were 
involved from the time of counselling about safe infant feeding during routine antenatal clinic 
visits until the focus group discussion. Thereafter, women wrote their infant feeding 
experiences, feelings, thoughts and concerns, on cards, as short phrases, one experience 
per card. Once completed, the cards were taped on a wall. The facilitator read aloud the 
contents of each card and guided participants in clarifying their understanding of the 
responses on each card to eliminate any ambiguity associated with the meanings of the 
words or phrases. The group had to reach consensus on the meaning of each card’s 
contents with the purpose of arriving at a socially constructed, shared meaning of the 
contents of each card among the participants. 
Assisted by facilitators, participants reviewed all the cards on the wall and clustered them 
into factors or common themes. When the majority of the cards were clustered, the 
facilitators helped participants to identify an appropriate label for each cluster. Any cards that 
were miscategorised were sorted into appropriate category. 
Individual interviews 
Individual interviews for breastfeeding women were guided by factors that emerged from the 
breastfeeding focus group discussion, and similarly for formula feeding women. With 
assistance of a trained counsellor I shared the focus group’s description of each factor with 
the individual woman and then engaged in a dialogue to explore the personal meaning and 
life history experiences of the woman on the factor. The following issue statements were 
presented during the interviews: “The focus group identified several themes describing their 
infant feeding experiences. Let’s look at these themes one at a time while you tell me about 
your experiences on each of the themes. “The focus group described theme “A” as 
“Reflecting challenges women face with breastfeeding…..” Tell me your experience, opinion, 
values or feelings with theme A”. Participants’ key phrases describing their experiences were 
recorded. 
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Participants also described the relationship between the factors identified in the focus group 
discussions. This was facilitated by asking the participant to speak about the three possible 
types of relationships between each pair of ‘factors’ as follows: A influences B (A→B), B 
influences A (A←B), or no clear relationship (A<>B). During interviews, this exercise was 
presented as follows: “Look at A and B, as you think about what you have said about these 
factors, do you see a direct connection between these two or some sort of influence between 
these two? Explain why you believe so or would you give an example from your own 
experiences, opinion, values or feelings with the relationship between A and B”. Exploring 
participants’ perceptions of relationships between ‘factors’ enabled a deeper understanding 
of how they experienced infant feeding. 
Factor Description and Analysis 
Two translators translated the audio transcripts into English, and back translated to validate 
the translations. The principal investigator and co-author (GH) were involved in writing the 
composite descriptions; discrepant descriptions were resolved through discussions. Quotes 
gathered from index cards that were generated by focus group participants, and transcripts 
of the focus group discussions were used to develop composite descriptions to illustrate the 
range of meaning for each factor. This was supplemented by the individual interviews 
resulting in rich descriptions for each factor.  
A summary description of the factors describing HIV-infected women’s infant feeding 
experiences was generated separately for women who breast- and formula fed. The SIDs 
(113) served as graphical representations of the system of factors and relationships among 
the factors describing women’s experiences. The SIDs served as a basis for further thematic 
analysis of women’s experiences relative to understanding their decision between breast- 
and formula feeding.  
Results 
A number of factors influencing HIV-infected women’s infant feeding practices were 
identified during the focus group discussion. There were three interacting processes 
influencing women’s decision to either breast- or formula feed. 
1. A general understanding of women’s experiences of whether to breast- or formula 
feed 
The decision to breast- or formula feed was on-going as the pressures influencing the 
women’s decision persisted beyond initiating either choice. Women had to make these 
decisions in the context of multiple (often competing or contradictory) influencing factors (see 
Figure 5.1) 
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Figure 5.1 Factors influencing HIV-infected women’s decision to breastfeed or formula feed 
(a) Women’s emotional investment 
Women were highly emotionally invested in their infant feeding practice. They became 
worried about people’s reactions to their practice. At the same time they wanted to make the 
right choice for their infants. In the quote below, the woman’s relief at being able to escape 
what would be an emotionally charged decision to formula feed was evident: 
“People encourage you to breastfeed when you do not want to. I was told that I am 
HIV positive during pregnancy. I was hurt because I knew that I was not going to 
breastfeed. I was scared that my friends and family members were going to laugh 
at me, they were already asking about breastfeeding. I had menstrual problems 
until I gave birth; I had planned to tell them (friends and family members) that was 
the reason why I was not breastfeeding. When I found out at the clinic that I can 
breastfeed, I was very happy.” (Breastfeeding woman) 
Conversely, a woman who elected formula feeding describes the importance of emotional 
support from her partner in making this decision: “I was afraid to formula feed because of 
people. My partner encouraged me to formula feed” (Formula feeding woman). 
(b) Influence of multiple factors 
 Women expressed confusion, frustration and dissatisfaction at the perceived number of 
(often competing or contradictory) factors influencing their practices. The factors included:  
1. Advice on infant feeding. Women received advice both from within and outside the 
healthcare system, either supporting or against a particular feeding option. 
“Nurses and counsellors said that it is good to breastfeed because breast milk 
protects against infections like diarrhoea. They also said that there is a risk that the 
Emotional investment 
Social and economic 
constraints 
Benefits and risks of feeding options 
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baby may get HIV infection. I did not use that advice (to breastfeed) because I was 
scared to transmit the HIV infection” (Formula feeding woman). 
Another woman, who decided to breastfeed, described how important clear, non-
contradictory advice from healthcare providers was important to her decision: 
 “At first I did not know that I can breastfeed when I am HIV positive. I wanted to 
formula feed my baby. I was advised at the clinic that breastfeeding is the best as 
the baby would not get illnesses like diarrhoea easily. The encouragement I got 
from the clinic gave me assurance that my baby would be safe, I then decided to 
breastfeed.” (Breastfeeding woman) 
2. Accurate understanding of risk.  
Women’s own understanding of preventive measures to reduce the risk of vertical 
transmission of HIV, awareness of HIV status of children who were on a specific feeding 
modality and perceptions about the risk of vertical transmission of HIV through breast milk 
were different. Together, their understanding of these issues pushed and pulled women 
towards both feeding options. These understandings also interacted with the advice women 
received from healthcare providers and significant others. The following quote illustrates how 
for one woman, her vicarious experience was more important than any information she 
receives: 
“I chose to formula feed because the bottle is 100% protective and the baby will 
not be HIV infected. My neighbour is HIV positive, she was breastfeeding and her 
baby got TB. I knew that if I breastfeed, my baby will be infected. Breast milk is 
good for those who are HIV negative.” (Formula feeding woman) 
3. Risk benefit ratio.  
The non-HIV related health benefits of either feeding option were in some cases perceived 
to be in conflict with the HIV-related health risks. In this way, deciding on an infant feeding 
option was perceived as a compromise between general health benefits and HIV 
transmission risk. 
“From the time I was pregnant, I always wanted my baby to be healthy. I like 
breastfeeding because a breastfed baby is different (healthier) from a formula fed 
baby. I was told at the clinic that if you formula feed, the baby is more at risk for 
illnesses like diarrhoea but when you breastfeed, you know you are giving the 
best.” (Breastfeeding woman) 
(c) Constraints of social and economic realities 
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Women reiterated the social constraints or benefits of each feeding option, describing their 
feeding practices within real limits. Social stigma was an important factor that forced women 
to choose breastfeeding they were not comfortable with. Women expressed their view about 
people’s perceptions about women who formula feed: “Most of the people think that if you 
are HIV positive, you can’t breastfeed. When you are formula feeding, people think you are 
HIV positive.” (Formula feeding woman) 
Similarly women’s practices were often dependent on economic constraints which included 
lack of money to buy food, for example this woman’s ‘choice’ to formula feed (at a time when 
formula milk was still supplied free of charge by the PMTCT program) was not a choice but 
the only option given her own lack of food: 
“I chose formula feeding because there is no food at home. I was afraid that my 
baby was not going to survive or would starve.” (Formula feeding woman). For 
some women, the constraints were work related; “I chose formula feeding 
because I am working and I do not have enough time to express breast milk.” 
(Formula feeding woman) 
2. A dynamic process that resulted in some women breastfeeding and others formula 
feeding. 
While almost all women experienced the infant feeding practice as a complex and recurring 
decision, some women ended up breastfeeding and others formula feeding. There were 
three main processes directing women either way; feeding information and feedback, fear of 
making the ‘wrong’ choice for their infant, and lastly, expectations, demands and responses 
from family and friends. These processes were on-going and continued after the women had 
made a particular feeding choice. Based on women’s emotional reactions and the value 
women put on multiple influential factors including social constraints, we have the basis for 
understanding their feeding experiences. There were continual pressures which could 
explain some women’s periodic switching between breast and formula feeding. 
(a) Information loops and incremental exposure to ‘advice’ 
Women received advice from within and outside the healthcare system incrementally. For 
example, during the antenatal period this woman was given information influencing her to 
breastfeed: 
 “I knew my HIV status in 2012. I did not know what to do. I even wanted to abort 
the baby because I thought my baby was going to be infected. I went to the clinic 
and the counsellor explained everything about breastfeeding while you are sick. I 
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have adhered to all the procedures they told me until I gave birth. At the clinic they 
explained to me how breast milk is important for baby’s health and for bonding with 
the baby. The nurses told me that I should not mix feed because of my HIV status 
and the fact that my baby might get infected.” (Breastfeeding woman) 
However, after delivery some women were discouraged from breastfeeding by healthcare 
providers and family members, for example: 
“I was initially told to breastfeed for 3 or 6 months. Later, the nurses at the baby 
clinic told me to stop breastfeeding and said that it would be my fault if the baby 
gets infected. My family and friends asked me to stop breastfeeding. Even my 
husband did not want me to breastfeed because we heard people saying that if 
you breastfeed when you are HIV positive the baby will get infected. They are not 
talking about the same thing, it is up to you to see if it is going to work or not. I had 
to select which advice to use.” (Breastfeeding woman) 
Similarly, women who formula fed described similar experiences with information changing 
over time, for example this mother described her regret at formula feeding and later learning 
about the benefits of breastfeeding: “I heard that it is not right sometimes to formula feed. I 
regret that I did not breastfeed because I was advised to bottle feed.” (Formula feeding 
woman) 
In general, healthcare providers, family members and friends were the main source of 
information for breastfeeding women, whereas, formula feeding women received their advice 
mainly from healthcare providers. A breastfeeding woman explained her personal 
experience: 
“I had decided to formula feed when I was pregnant but when I delivered the 
nurses advised me to breastfeed because my CD4 count was high and I was 
happy. I trusted the advice I got from the nurses and I felt my baby was not going 
to be infected. When one of the mothers taking part in this study told me that her 
baby became HIV positive, I was very scared to continue breastfeeding, I tried 
formula feeding but the baby did not like the formula milk. People give you difficult 
information and it is very stressful.” (Breastfeeding woman) 
(b) Fear of the wrong decision 
For all women, the primary motivation for their infant feeding practice was the health of their 
child. Women making the decision to breastfeed were plagued by worries that their child 
may contract HIV. At the same time these women sought emotional affirmation that breast 
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milk was better for their baby. Conversely, women who made the decision to formula feed 
expressed heightened perceptions of the risk of HIV transmission through breast milk, 
emotionally justifying their practice to give formula milk to their child.  
The tension between the knowledge of the risk of vertical transmission of HIV through breast 
milk, and mothers’ desire to choose a feeding option that is optimal for their baby’s health 
played out in every narrative of infant feeding practice. Breastfeeding women had lower 
perceptions about the risk of HIV transmission through breast milk than women who formula 
fed. Some described a belief that the risk was low as influenced by feeding practices and 
health status, as illustrated in this quote: “I was happy to breastfeed despite my HIV status 
because my CD4 count was high and I knew that I was going to exclusively breastfeed 
therefore it was unlikely that my baby was going to be infected.” (Breastfeeding woman) 
Some breastfeeding women demonstrated their understanding that antiretroviral prophylaxis 
needs to be taken regularly: 
 “I was happy that I was breastfeeding because I knew my baby was getting all the 
nutrients from the breast milk. I was scared sometimes because I felt like I was a 
danger to my child. The first day after delivery I could let the baby breastfeed then 
take the breast out and give it to my baby again because a lot of things were going 
through in my mind. I got nevirapine and other medication but nurses told me that 
there is a risk that the baby can get infected. I am not sure if the medication is 
100% protective. I always try to take the medication and give the baby his 
medication so that my baby can be safe.” (Breastfeeding woman) 
However, for some women concern increased when healthcare providers and significant 
others discouraged on breastfeeding. As seen in the two quotes below, inconsistencies in 
the messages made women uncertain about the risks of breastfeeding. Vicarious and 
personal experiences could cause some women to lose confidence in breastfeeding and 
(sometimes) switch to formula feeding: 
 “Sometimes people at the clinic confuse me, some say do not breastfeed and 
some say breastfeed the baby, the breast never gets sick. This makes me 
confused because the infection is in my body. I am still confused whether it is good 
or bad to breastfeed when you are HIV positive. I was scared to continue 
breastfeeding. Nurses told me to continue breastfeeding but I did not trust them 
and I stopped breastfeeding. I never breastfed again, I gave my baby formula 
milk”. (Breastfeeding woman) 
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 “My second child, whom I breastfed tested HIV positive whilst I was breastfeeding 
my third child. I thought of stopping breastfeeding my third child.” (Breastfeeding 
woman) 
In contrast, women who decided to formula feed described their perception of the risk of HIV 
transmission through breast milk as relatively high. 
Some women were unhappy about the breastfeeding advice they got from healthcare 
providers because of health challenges (increase in viral load) they had after initiating 
breastfeeding, because they felt that they were wrongly informed: 
“At first I was advised to breastfeed at the clinic and when my viral load was high 
they advised me to stop breastfeeding, and start formula feeding. I think they just 
play with our minds at the clinic. They knew my viral load was high and they told 
me to breastfeed.” (Breastfeeding woman)  
(c) Family and friends expectations and demands 
Women described the common perception in their community that an HIV–infected woman 
can only formula feed, and consequently, risking involuntary disclosure of their HIV status or 
being labelled as “HIV positive”. As much as women wanted to make the right infant feeding 
decision, they also tried to balance between the competing medical and social benefits of 
each feeding option. However, women who chose breastfeeding and those who chose 
formula feeding dealt with the two competing issues differently. Subsequently the demands 
and responses to their decisions were different. Breastfeeding women treated the medical 
and social benefits of breastfeeding as equally important. While nutritional benefits of breast 
milk were some of the reasons for wanting to breastfeed, for some the reasons were related 
to the social limits in which women had to choose their feeding practice. Hence, there were 
fewer demands from family and friends’ on breastfeeding women to explain the reasons why 
they were breastfeeding, because they had conformed to social expectations of motherhood. 
Women who formula fed put less value on the social benefits compared to the medical 
benefits: 
“Most of the people think that if you are HIV positive you can’t breastfeed. When 
you are formula feeding, people think you are HIV positive. Because I wanted to 
protect my son from HIV infection I did not care what people were saying.” 
(Formula feeding woman) 
Compared to breastfeeding women, there were more demands from family and friends on 
women who formula fed to explain their reasons for not breastfeeding. Women responded 
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differently, some chose not to disclose their HIV status in fear of being discriminated against 
in the community: 
 “My family asked me where I get a lot of formula milk, and whether I was not sick 
(HIV positive). I told them that I get the formula from the clinic because my baby 
does not have a father. I did not disclose because if people know that you are 
HIV positive, they do not eat your food or come to your house. When I go to the 
clinic to collect the tins, I go with a big bag and when I throw away empty tins I 
put them in a plastic so that other people do not see” (Formula feeding woman). 
For those who disclosed, some described positive and others negative social responses: 
“My brother wanted me to breastfeed, when I told him my HIV status and why I 
was not breastfeeding, he accepted. He now likes my baby and he says that the 
baby is growing well.” (Formula feeding woman) 
“When I knew that I was HIV positive, I told my brother. My brother now keeps 
swearing at me about my HIV status. We no longer talk to each other because he 
did not want me to formula feed.” (Formula feeding woman) 
The three processes described above were interlinked, at times working in confluence to 
support women’s decision and at others pulling them in the opposite direction. Importantly, 
the complexities of the three processes were compounded by their interaction, meaning 
every woman described continual pressures to decide, re-decide, and justify her infant 
feeding practices. 
Discussion 
Our findings provide the lived experiences of HIV-infected women wanting to make an 
appropriate feeding practice for their infants.  Women had a range of values which 
influenced their understanding of the feeding information they received and how they 
decided on a feeding practice for their infants. Women reacted to their own perceptions of 
what they felt is best for their infants and to the continual pressures influencing their 
decisions which persisted beyond initiating either choice. 
Healthcare providers either supported or were against a particular feeding option, probably 
due to their own perception (128). The Tshwane Declaration 2011 and the current feeding 
recommendations (9) that marked a turning point in support of breastfeeding for HIV-infected 
women probably resulted in conflicting messages that were shared between the women and 
healthcare providers. Some of the healthcare providers seem to have adopted an 
understanding that HIV-infected women can only formula feed, a view that was also common 
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among HIV-infected women, their families, and the community. Our findings were consistent 
with those found in settings that did not experience high uptake of formula feeding, for 
example in Malawi, where healthcare workers found it difficult to advice continued 
breastfeeding by HIV-infected women (128). Women were then confused and worried that 
their child may contract HIV through breast milk because of the inconsistent information they 
received. Furthermore, concerns about HIV-related stigma and continual demands regarding 
infant feeding practices from families and significant others could have pushed some women 
to switch between feeding modality. Our results showed the need to refine the quality of 
infant feeding counselling to avoid possible inconsistences in the messages shared between 
women and healthcare providers. Besides the medical benefits and risks of either feeding 
options, infant feeding guidelines need to reinforce contextual and social issues to overcome 
the challenges women face when making infant feeding decisions. 
PMTCT programs adopting a universal breastfeeding policy need to address home food 
shortages, as a limitation of HIV-infected women’s infant feeding practice. The policies need 
to guide healthcare providers on how to appropriately advise pregnant women in cases were 
a woman’s child from previous pregnancy may have contracted HIV infection through breast 
milk.  
Our findings confirm those of Ijumba and colleagues (129), and provide additional data 
comparing the experiences of breastfeeding and formula feeding HIV-infected women during 
a time the PMTCT program was switching from promoting formula feeding to promoting 
breastfeeding. The findings underscore the importance of regarding infant feeding practice 
as a social exercise, taking place in a system comprising the HIV-infected woman, the infant, 
multiple factors and the relationships among these (130,131). 
Most of the women were taking cART. However, from our focus group discussions and 
interviews it was unclear whether women’s attitude towards lifelong cART affected their 
infant feeding practices; we therefore explored this further in the longitudinal cohort study.  
Women who formula fed in our qualitative study were more likely to be never married 
compared to breastfeeding women. Anticipated and real social pressure by family and 
friends were important in women’s decision-making experiences, and never being married 
seems an important influence on how such social pressures (perpetrated by and in relation 
to the child’s father) influenced the women’s decisions. This finding, plus the small sample 
size of women who participated in the qualitative study, may limit the generalizability of our 
findings especially to social context where not living with a common law spouse is not often 
the norm. 
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In conclusion, HIV-infected women were confused because of conflicting information they 
received from healthcare providers. There is an urgent need to engage and reorient HIV-
infected women, their families, the community and healthcare providers, about the rationale, 
and reasons for changes in infant feeding guidelines. Infant feeding guidelines for HIV-
infected women should integrate considerations of women’s interpretation of information 
about risks and benefits of infant feeding options, formula feeding stigma and the quality of 
infant feeding counselling affected women’s infant feeding practices. 
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Chapter 6 
Summary of findings and conclusions 
 
Brief background and study justification 
Finding an appropriate infant feeding option for HIV-infected women in low-resourced setting 
has been a challenge, in HIV epidemic history. Guidelines on infant feeding for HIV-infected 
women have changed many times based on new study findings. The most recent changes 
led to the withdrawal of formula feeding in favour of breastfeeding that has to be continued 
until 12 months. The changes were informed by studies showing the protective role of 
breastfeeding against respiratory infections, diarrhoeal disease and better infant growth. The 
significant reduction in HIV transmission through breastfeeding by cART given either to the 
HIV-infected woman or infant further strengthened the support for breastfeeding. Many 
PMTCT programs are now promoting breastfeeding for HIV-infected women, including the 
Western Cape, where until recently there was high uptake of formula feeding relative to 
breastfeeding. 
Of concern, was that most of the studies informing infant feeding guidelines for HIV-infected 
women in low-resourced settings were performed under highly controlled conditions, where 
much effort is put in controlling guideline adherence by investigators and participants. As a 
result making them less reliable for predicting the real life effects of the feeding options on 
important clinical outcomes because such efforts are rare in real life practise. Moreover, 
feeding guideline development and implementation has focused more on medical outcomes 
but less on social and contextual factors that may relate directly to uptake of the option by 
HIV-infected women. Importantly, these factors are not well established for the current 
breastfeeding recommendations. Understanding HIV-infected women’s socially constructed 
views or norms on feeding options, according to our study, provide an insight into how and 
why the effects of the feeding options in usual care and highly controlled settings are similar 
or not.  
Study objectives and a critique of the rigour of study methods 
A longitudinal cohort study reflecting infant feeding practices outside trial settings was 
performed to provide reliable findings to guide HIV-infected women and healthcare 
authorities in decision making. The objectives of the longitudinal cohort study were to: a) 
describe HIV- infected women’s infant feeding practices, b) compare infant feeding practices 
of HIV-infected and HIV-uninfected breastfeeding women c) assess growth and infection-
related hospitalizations among predominantly breastfed and predominantly formula fed HIV-
exposed uninfected infants in primary healthcare settings, over a 12 months period.  
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Women’s socially constructed views on breastfeeding and formula feeding were explored in 
a sub-set of HIV-infected women who were followed-up for at least 6 months post-delivery in 
the longitudinal cohort. Interactive qualitative analysis methods were used, where women 
described, labelled their feeding experiences, and articulated perceived relationships among 
their experiences.  
The study designs were determined by their appropriateness for the research questions. The 
longitudinal cohort study design was appropriate to test theoretical propositions that were 
expressed in the hypotheses. Women chose their feeding options, to reflect what happens in 
usual care settings. Any effect of belief in the feeding option the woman chose was 
acknowledged as a potential mechanism of action whose effect was worth evaluating. The 
qualitative study provided non-clinical factors explaining the infant feeding practices that 
were observed in the longitudinal cohort. 
Main findings and significance of findings 
Despite, the recommendations for breastfeeding, few HIV-infected women chose this option, 
and among those who did, many switched to formula feeding early. More HIV-infected 
women switched to predominant formula feeding during follow-up; however, the proportion of 
HIV-uninfected women who switched to predominant formula feeding was relatively high. 
These differences were seen from about two weeks, and persisted throughout follow-up. By 
about 4 months, half of the HIV-infected women had switched to predominant formula 
feeding. Predominantly breastfed infants were exclusively breastfed for a short duration and 
had poorer weight velocity compared to predominantly formula fed infants in the 2 to 4 
months age interval. There tended to be fewer infection-related hospitalizations among 
predominantly breastfed compared to predominantly formula fed infants. However, the 
protection against infections by breastfeeding was minimal and insignificant. Early switching 
to formula feeding by breastfeeding women is an unintended consequence of the current 
recommendations as this increase the risks of death due to diarrhoeal disease.  
As gained from the focus group discussions and qualitative interviews, it was interesting to 
note for future guidelines that the dual infant feeding option employed by the Western Cape 
PMTCT program while transitioning from formula feeding policy to breastfeeding caused 
confusion among healthcare providers who either supported or were against a particular 
feeding option because some of them seem to have adopted an understanding that HIV-
infected women should only formula feed. This view was also common among HIV-infected 
women and their families, despite current information on the benefits of breastfeeding. The 
women had difficulty dealing with opinions of family members and healthcare providers 
regarding breastfeeding while HIV-infected, possibly explaining why some women stopped 
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breastfeeding. Women constantly feared that their infants might contract HIV through breast 
milk, because of the conflicting messages received. In addition, women’s own understanding 
of non-HIV and HIV-related benefits and risks, formula feeding stigma and the quality of 
counseling affected their decisions on infant feeding practices.  
Breastfeeding is now known to be safe for HIV-infected women but as noted from the 
qualitative interviews, what is important is how to get the message across in new guidelines 
support for HIV-infected women. We found that HIV-infected women required support with 
the correct attitudes for breastfeeding. The Western Cape PMTCT program must ensure that 
healthcare providers follow the principles and guidance provided by provincial infant feeding 
guidelines to avoid giving conflicting messages. Primary healthcare services are encouraged 
to provide in-depth training in breastfeeding for all health care staff or develop office 
practices that promote and support breastfeeding. Education of both HIV-infected women 
and their families is an essential component of successful breastfeeding. 
Our study was unique in that it is the first to describe heterogeneity in infant feeding 
practices among HIV-infected women during a transition of a dual infant feeding system, 
outside of a trial setting. The study provides the first data in Western Cape Province to 
uncover poor adherence to breastfeeding. We were also able to do an in-depth analysis of 
the effects of these behavioural shifts on infant growth and infection-related hospitalizations. 
The qualitative aspect also enhanced the findings of the longitudinal cohort as it helped to 
evaluate in part reasons for women’s different infant feeding practices, using a sub-set of the 
same group of women in the cohort study.  
Our study had several limitations. The study had challenges of inadequate enrolment and 
high early attrition rate that was not expected. In addition, few HIV-infected women chose 
the breastfeeding option. Only 98% of the enrolment target was reached (184 of a targeted 
188 HIV-infected women and their infants; breastfeeding group (n = 80), formula feeding 
group (n = 104)) following extension of the enrolment from 9 to 18 months. Financial 
constraints limited further extension of enrolment period. Of the 184 HIV-infected women 
and their exposed infants, only 121 (breastfeeding (n = 50), formula feeding (n = 71)) with at 
least one follow-up visit were included in the analysis. The study team attempted to increase 
participants’ attendance of study visits. Strategies included considering participants’ personal 
schedules when setting study appointments, offering free doctor consultations, appropriate 
referral to specialized clinics for infants who required special care, and remuneration of R100 
(~US$10) at each follow-up visit to compensate for their time. This marked deviation in 
allocation of groups could have significantly reduced the power of the study to find any 
differences between predominantly breastfed and formula fed infants should there have 
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been any true differences in infant growth and risk for infectious morbidity. The small sample 
size due to high attrition rate reduces our confidence to draw any definite conclusions from 
this study for differences in infant growth and risk of infectious morbidity between 
predominantly breastfed and formula fed HIV-exposed uninfected infants. Although we have 
no obvious reason that the infant growth rate and rate of infection-related hospitalization 
observed in the cohort that continued in the study would have been different from infants 
who did not continue with the study, attrition bias cannot be ruled out. We may not have 
found important clinical difference in infectious morbidity between breastfed and formula fed 
infants because the analysis focused on severe infections requiring hospitalizations. It is 
plausible that any pattern may have emerged should less severe infections at sick clinic 
visits had been included. Furthermore, we may not have found important clinical differences 
in infectious morbidity between breastfed and formula-fed infants due to exclusion of the 
infants at higher (infants <2000g and <36 weeks gestation at birth). This was done with 
intent to determine whether there is evidence of a difference for infant feeding practices 
other than other factors that determine risk for postnatal growth failure and infectious 
morbidity. We acknowledge that there is a potential for unmeasured and residual 
confounding because the study could not conducted in a randomized fashion, due to ethical 
implications of randomly assigning feeding behaviour. Infant feeding practices could have 
changed between follow-up visits, and the study may not have been able to capture these 
changes given the dynamics and complexity of infants feeding practices. Poor adherence to 
breast feeding was the most important unanticipated observation. 
Despite, the limitations of our study, we can conclude that all women, irrespective of their 
HIV status need to be educated that breastfeeding is the feeding of choice in this setting. 
Strategies to promote and sustain continued breastfeeding by women, that would result in a 
significant impact on growth and general health of their children are urgently needed. The 
strategies should be guided by factors affecting women’s feeding practices such as women’s 
interpretation of information about risks and benefits of infant feeding options, formula 
feeding stigma and quality of infant feeding counselling. 
Implications for research 
The main study aims were to: a) describe infant feeding practice of HIV-infected and 
uninfected women b) assess the effectiveness of predominant breastfeeding and formula 
feeding, in improving growth and reducing infection-related hospitalizations of HIV-exposed 
uninfected infants in primary healthcare settings c) explore HIV-infected women’s 
experiences and perceptions on breastfeeding and formula feeding. Each of these three 
aims was achieved, though there are new emerging issues worth further investigating. The 
following research questions are proposed: a) What strategic interventions are needed to 
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promote and sustain continued breastfeeding by HIV-infected women? b) Could it be that 
breastfeeding was not well established in this setting such that the protection against 
infections by breastfeeding was minimal and insignificant, when, in fact, breastfeeding could 
have been significantly protective?  
“The PhD Path: Experience and Lessons Learned”  
The critique from journal peer reviewers and during meetings and conference presentations 
helped me focus my research project, made it more exciting and made me want to work 
harder. My skills for writing protocols for funding were sharpened as shown by the number of 
grants obtained. I developed the ability for independent, critical judgement and was able to 
analyse, understand and describe patterns in my research data rationally and objectively. I 
acquired the skills to link the conclusions and the theoretical perspectives that guided the 
research study, thus displaying high level of thinking and reasoning. The timely feedback I 
received from my promoters helped me to reach my research goals – and that kept me in a 
happy state.  
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Abstract 
Introduction: Guidelines in resource-poor settings have progressively included interventions 
to reduce postnatal HIV transmission through breast milk. In addition to HIV-free survival, 
infant growth and non-HIV infections should be considered. Determining effect of these 
interventions on infant growth, and non-HIV infections will inform healthcare decisions about 
feeding HIV-exposed infants. We synthesise findings from studies comparing breast to 
formula feeding, early weaning to standard-duration breastfeeding, breastfeeding with 
extended antiretroviral to short-course antiretroviral prophylaxis, and alternative preparations 
of infant formula to standard formula in HIV-exposed infants, focusing on infant growth and 
non-HIV infectious morbidity outcomes. The review objectives were to collate and appraise 
evidence of interventions to reduce postnatal vertical HIV-transmission, and estimate their 
effect on growth and non-HIV infections from birth to two years of age among HIV-exposed 
infants.  
Methods: We searched PubMED, SCOPUS, and Cochrane CENTRAL Controlled Trials 
Register. We included randomised trials and prospective cohort studies. Two authors 
independently extracted data and evaluated risk of bias. Rate ratios and mean differences 
were used as effect measures for dichotomous and continuous outcomes, respectively. 
Where pooling was possible, we used fixed effects meta-analysis to pool results across 
studies. Quality of evidence was assessed using the GRADE approach. 
Results and discussion: Prospective cohort studies comparing breast- versus formula-fed 
HIV-exposed infants found breastfeeding to be protective against diarrhoea in early life (risk 
ratio (RR)= 0.31; 95% confidence interval (CI) 0.13 to 0.74). The effect of breastfeeding 
against diarrhoea (hazard ratio (HR) = 0.74; 95% CI 0.57 to 0.97) and respiratory infections 
(HR = 0.65; 95% CI 0.41 to 1.00) was significant through 2 years of age. The only 
randomised controlled trial available showed breastfeeding tended to be protective against 
malnutrition (RR = 0.63; 95% CI 0.36 to 1.12). We found no statistically significant 
differences in the rates of non-HIV infections or malnutrition between breastfed infants in the 
extended and short-course antiretroviral prophylaxis groups.  
 
Conclusions: Low to moderate quality evidence suggests breastfeeding may improve 
growth and non-HIV infections outcomes of HIV-exposed infants. Extended ARV prophylaxis 
does not appear to increase the risk for HIV-exposed infants for adverse growth or non-HIV 
infections compared to short- course ARV prophylaxis.  
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PROSPERO Number: ‘Completed review’ 
Introduction 
Human immunodeficiency virus (HIV) infection among children is a public health concern 
especially in poorly resourced countries [1]. Most children acquire HIV infection through 
mother-to-child transmission (MTCT) [2]. Approximately 2.5 million children are living with 
HIV/AIDS worldwide [3]. Although the proportion of HIV-attributable death among children 
less than 5 years of age is declining worldwide, HIV/AIDS is still a leading cause of 
premature death in Southern African children [4]. In the absence of antiretroviral (ARV) 
treatment, one third of HIV-infected children die by one year of age and about 50% by 2 
years of age [4]. Infectious diseases and nutritional complications are the predominant 
underlying causes of mortality in these children [4]. 
 
HIV may be vertically transmitted in pregnancy, labour, delivery, or through breast milk. 
Without interventions, 15-30% of infants are vertically infected; breastfeeding increases the 
risk to 20-45% [5]. Strategies to reduce postnatal vertical transmission of HIV focus on 
reducing transmission through breast milk. HIV-infected mothers in high-income countries 
are recommended to completely avoid breastfeeding [6]. However, in poorly resourced 
countries where formula feeding does not generally meet AFASS criteria (Acceptable, 
Feasible, Affordable, Sustainable, and Safe), avoiding breastfeeding increases the risks of 
infant mortality and infectious morbidity [7].  
Description of the intervention 
The efficacy of ARV regimens in reducing HIV vertical transmission through breast milk has 
been demonstrated in several randomised controlled trials (RCTs) [8-11], these interventions 
have since been incorporated into the World Health Organization (WHO) guidelines on infant 
feeding by HIV-infected mothers [12].  
 
WHO 2013 prevention of MTCT (PMTCT) guidelines recommend that all HIV infected 
pregnant women  receive highly active ARV treatment (HAART),  until at least one week 
after cessation of breastfeeding or after delivery when formula feeding, but should preferably 
be continued as life-long therapy regardless of CD4 count [12]. Mothers with CD4 count ≤ 
500cells/mm3 or WHO clinical stage 3 or 4 disease are recommended to continue lifelong 
ARVs. HIV-exposed infants on breast milk are recommended to receive once-daily 
nevirapine (NVP) prophylaxis until they are fully weaned. Formula fed infants should receive 
4-6 weeks of daily NVP or twice-daily Zidovudine (ZDV) [12].   
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Effect of postnatal MTCT interventions on infant growth and non-HIV infections  
Compared to infant formula, breast milk protects against gastrointestinal and respiratory tract 
infections and improves overall survival [13]. Breastfeeding also promotes optimal child 
growth until 2 years of age [14]. 
 
ARVs drugs minimize postnatal HIV transmission through breast milk by reducing breast 
milk viral load. As ARVs have clinical and laboratory adverse effects, their safety in HIV-
exposed children should be considered. Baroncilli et al. reported a high risk of anaemia in 
HIV-exposed infants exposed to HAART with ZDV alone compared to HAART without ZDV, 
which disappeared at 1 month of life [15]. Grade 3-4 hepatoxicity was reported in infants 
exposed to NVP for at least 5 days [16]. Neonatal exposure to Lopinavir/ritonavir (LPV/r) has 
been associated with cardiac toxicity and adrenal dysfunction [17]. Lamivudine exposure is 
safe in HIV-exposed infants [18]. While side effects would not negate the benefits of ARVs in 
preventing HIV transmission, it is important for health policy makers to have accurate 
estimates of the anticipated risks of such effects when introducing these interventions into 
clinical practice. 
 
Why it is important to do this review 
A Cochrane review appraised evidence for the efficacy of postnatal HIV PMTCT 
interventions in preventing HIV transmission, and improving HIV-free survival [19]. However, 
in addition to their efficacy in preventing HIV transmission, policy makers should consider the 
effects of these interventions on infant growth and susceptibility to non-HIV infections.  
 
Contradictory findings of the effects of different postnatal PMTCT interventions on infant 
growth and non-HIV infectious morbidity were reported in clinical trials and observational 
studies; therefore the true effects of the interventions on these outcomes is uncertain. To 
inform decision-making about HIV PMTCT recommendations, this review aims to synthesize 
findings from studies comparing the effects of different postnatal interventions for PMTCT of 
HIV on infant growth and non-HIV infections, with follow-up periods of between 3 to 24 
months of age. 
 
Objectives 
To collate and appraise evidence of interventions to reduce postnatal vertical HIV-
transmission in HIV-exposed infants, and estimate their effect on: 
Primary: 
Growth from birth to two years of age 
Secondary:  
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Non-HIV infections from birth to two years of age 
   
Methods 
Criteria for considering studies for this review  
Studies 
• RCTs of postnatal interventions to prevent vertical transmission of HIV, which 
included assessment of infant growth or non-HIV infections. 
• RCTs assessing effect of established postnatal interventions for prevention of vertical 
transmission of HIV on infant growth or on-HIV infections.  
• Cohort studies were also included if the intervention (e.g. mode of feeding) could not 
ethically be randomised. 
  
Participants 
HIV-infected mothers and their infants 
 
Interventions 
Intervention aimed at reducing HIV vertical transmission. 
 
Primary outcomes 
• Weight-for-age (WAZ), weight-for-length (WLZ), length-for-age (LAZ), and head 
circumference-for-age (HCA) z-scores and malnutrition. 
• Non-HIV infections e.g. respiratory tract infections, gastrointestinal infections. 
Search methods for identification of studies 
Electronic searches 
Search strategies developed by The Cochrane Collaboration HIV/AIDS Review group were 
used to search for studies [19]. PubMED (24 April 2013), SCOPUS (24 April 2013), and 
Cochrane CENTRAL Controlled Trials Register (11 March 2013) were searched without 
language, time or publication status restrictions (Additional Table 1: Search strategies). 
Dates indicate the time when searches were last performed in each database. The reference 
lists of included studies were searched for studies.  
 
Data collection and analysis  
 Selection of studies 
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Two reviewers (MZ and GM) independently reviewed abstracts of electronic search results. 
Full texts of potentially relevant articles were retrieved and independently examined for 
eligibility.  
 
Data extraction  
The following data were independently extracted in duplicate: study design, study duration, 
methodological quality, study interventions, and outcomes. Discrepancies were resolved 
through discussion. 
 
Assessment of risk of bias in included studies 
The Cochrane Collaboration's risk of bias tool was used to assess the methodological quality 
of each selected study [20]. Two authors (MZ and GM) independently assessed the risk of 
bias. The following domains were assessed: sequence generation; allocation concealment; 
blinding of participants, personnel, and outcome assessors; whether incomplete outcomes 
data were adequately addressed; selective reporting; and other bias. 
 
ClinicalTrial.gov and Current Controlled trial registries were searched for protocols of 
included studies. If the protocol was unavailable, the methods and results sections were 
compared to assess the potential for selective reporting bias.  
 
Measures of treatment effect      
When included publications presented summary data separately for each intervention group, 
we calculated risk ratios (RR) for binary outcomes and mean differences (MD) for continuous 
outcomes, and associated 95% confidence intervals (CI). Otherwise we have directly 
presented the effect estimates (RR, hazard ratio (HR), and odds ratios (OR) reported in the 
publications.  
For infectious morbidity events we assumed that the occurrence of each outcome per 
participant is a random variable following a Poisson distribution. The normal approximation 
to the Poisson distribution was used to calculate confidence intervals (CI) for mean 
differences in incidence of infectious morbidity outcomes. The 95% CI for the mean 
difference was calculated as:  
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( λ  −	 λ ) ± 1.96× λ
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 , where λ	1 and λ	2 are estimated average counts of a 
specific infection in group 1 and 2, and n1 and n2 are numbers of infants with complete 
follow-up data in each group [21]. 
Unit of analysis issues 
Repeated observations on participants 
When results were presented for more than one time point, the following approaches were 
used to obtain single effect measures: 
For infectious events we computed the total number of events experienced during the entire 
follow-up period for each intervention group. For growth outcomes, summary data were 
extracted at the longest follow-up time point. 
 
Multiple intervention groups 
Experimental intervention groups deemed sufficiently comparable were combined for 
pairwise comparison with the control group. For dichotomous outcomes, sample size and 
outcome events were summed across combined groups. For continuous outcomes, means 
and standard deviations (SD) were combined using the following formulas [20]. 
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Where N1, M1 and SD1 are sample size, mean and standard deviation of group 1, N2, M2, 
SD2 are the corresponding values of group 2.  
 
Studies using a factorial design 
One report was from a trial that used a factorial design [11]. We only report on the effect of 
antiretroviral interventions in this review. Reports of the study did not suggest an important 
interaction between the two interventions.  
 
Dealing with missing data 
Authors of twelve studies were contacted for missing information; the requested information 
being obtained for six studies. The potential impact of missing data was considered during 
risk of bias assessment. Meta-analysis was repeated, excluding studies with attrition rates 
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>20% to assess the robustness of the results to missing data, and both estimates are 
presented.  
   
Assessment of heterogeneity 
Substantial statistical heterogeneity was defined as an I2 statistic > 50% [20]. 
  
Assessment of publication bias 
Too few studies were included in each comparison to enable investigation of publication 
bias. 
 
Data synthesis 
Fixed-effects meta-analysis using the Mantel-Haenszel method for dichotomous outcomes 
and the Inverse-variance method for continuous outcomes were used to pool results across 
studies [20]. Where meta-analysis was inappropriate, individual study results were reported 
separately.  Review Manager 5.1 was used for analysis. 
 
Quality of evidence 
The Grades of Recommendation Assessment, Development and Evaluation (GRADE) 
approach was used to rate quality of evidence [22]. In evaluating the quality of RCT 
evidence, we considered the following in whether to downgrade the quality of evidence: 
methodological limitations, inconsistency in study results, indirectness, imprecision and 
publication bias. For observational studies, we considered the following factors in 
determining whether to upgrade the quality of evidence: large observed effect and whether 
plausible confounding would change the intervention effect. Our ratings for the breastfeeding 
versus formula feeding and the breastfeeding with extended versus short-course ARV 
prophylaxis comparisons are presented in Table 2 and 3, respectively. 
 
Results 
Included studies 
We identified fourteen reports from 7 RCTs and 3 prospective cohort studies (Figure 1) 
conducted in: South Africa (3), Zambia (1), Malawi (1), USA and Brazil (1), Cote d'lvoire (1), 
Tanzania (1), Kenya (1), Burkina Faso, Kenya and South Africa(1) and South Africa, 
Tanzania, Uganda and Zimbabwe (1) (Additional Table 2: Characteristics of included 
studies). Ten studies were excluded on review of full articles (Additional Table 3: Excluded 
studies). 
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Figure 1.  Flow diagram of screening process 
1661 titles identified by electronic 
searches after duplicates removed 
19 articles reviewed and 5 additional articles 
identified through reference list search 
1642 articles excluded (did not meet 
inclusion criteria on review of titles and 
abstracts) 
10 articles excluded after full review 
(Reasons - not comparing at least two 
postnatal PMCTC interventions, review 
outcomes not addressed) 
14 articles met all review eligibility 
criteria and are included in review 
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Types of interventions 
Table 1 summarises the studies included and outcomes assessed under each comparison.  
Table 1: Summary of included studies and outcomes assessed for each comparison  
 
Comparisons Studies 
(Sample size) 
Outcomes 
assessed 
Studies 
Breastfeeding vs. Infant 
formula feeding  
4 (1741) Malnutrition 
 
 
 
Growth 
 
Respiratory tract 
infections 
 
 
 
Diarrhoea 
Becquet et al.,2007 
Mbori-Ngacha et 
al.,2001 
 
Kindra et al.,2012 
 
Mbori-Ngacha et 
al.,2001 
Venkatesh et al.,2011 
 
 
Mbori-Ngacha et 
al.,2001 
Becquet et al.,2007 
Venkatesh et al.,2011 
Kindra et al.,2012 
 
Breastfeeding with extended 
ARV prophylaxis vs. 
breastfeeding with short 
course ARV prophylaxis 
5 (7956) Growth faltering 
 
 
 
 
 
Pneumonia 
 
 
 
 
 
Gastroenteritis 
 
 
 
 
 
Meningitis 
 
 
Sepsis 
 
 
Jamieson et al.,2012 
Kesho Bora 2011 
Kumwenda et al.,2008 
 
 
 
Coovadia et al.,2012 
Kesho Bora, 2011 
Gray et al.,2005 
Kumwenda et al.,2008 
Kesho Bora, 2011 
Jamieson et al.,2012 
 
Coovadia et al.,2012 
Kesho Bora, 2011 
Gray et al.,2005 
Kumwenda et al.,2008 
Jamieson et al.,2012 
 
Kumwenda et al.,2008 
Jamieson et al.,2012 
 
Kumwenda et al.,2008 
 
Early cessation  of 
breastfeeding vs. standard 
duration 
 
2(451) Growth 
 
Prolonged diarrhoea 
Arpadi et al.,2008 
 
Fawzy et al.,2011 
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Chemically or biologically 
acidified infant formula vs. 
standard infant formula 
 
1(132) 
 
Growth 
Bronchopneumonia 
Gastroenteritis 
 
Velaphi et al.,2008 
 
 
 
 
 
Concentrated infant formula  
vs. standard infant formula 
1(1686) Growth Winter et al.,2009 
Chemical acidified infant 
formula milk with or without 
prebiotics and nucleotides  
1(84) Growth 
 
 
Cooper et al.,2010 
 
 
Risk of bias in included studies   
The risk of bias summary presents authors' judgments on risk of bias in each domain for 
each study separately (Figure 1), while the risk of bias graph presents the risk of bias in 
each domain as a percentage across all included studies (Figure 2). A summary of our 
findings on study methodological quality for each domain  follows below. 
 
Allocation (selection bias)   
Random sequence generation was adequate in 10 studies [9] [11] [23-30]. The method of 
sequence generation was not reported in 1 study [31]. Risk of bias was high for 3 
observational studies because participants self-selected into comparison groups [32-34]. 
 
Methods of allocation concealment were adequate in 10 studies [9] [11] [23-27] [29-31]. One 
study did not report how treatment allocation was concealed [28]. The risk of bias in this 
domain was high for the 3 observational studies [32-34]. 
 
Blinding (performance bias and detection bias)   
 
Participants and personnel (performance bias) 
Seven studies were assessed as having low risk of participant performance bias [9] [11] [24] 
[26,27] [30,31]. Five studies were at high risk because participants were unblinded and it 
was felt that knowledge of their intervention allocation, rather than the intervention itself, 
could have affected participants’ outcomes [23] [25] [28] [33, 34]. Two studies were unclear 
on whether participants were blinded [29] [32]. Risk of personnel performance bias was low 
in 8 studies [9] [11] [23, 24] [26, 27] [30, 31]. Two studies were at high risk because 
personnel may have treated participants differently through knowing their intervention 
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allocation, thereby influencing the outcomes [25] [33]. It was unclear in 4 studies whether 
personnel were blinded [28, 29] [32] [34]. 
  
Outcome assessment (detection bias) 
Risk of detection bias was judged to be low in 10 studies [9] [11] [23- 27] [31] [33, 34]. One 
study was at high risk because outcomes were ascertained through participants’ verbal 
reports and outcome definitions were relatively subjective [28]. It was unclear whether 
outcome assessors were blinded in three studies [29,30] [32]. 
 
Incomplete outcome data (attrition bias)   
Seven reports with an attrition rate below 20% were judged to have low risk of attrition bias 
[9] [11] [27- 30] [33]. Five reports were judged high risk [23] [26] [31, 32] [34], and 2 studies 
were unclear [24, 25].  
 
Selective reporting (reporting bias)   
Protocols were available for five studies [9] [11] [23] [27] [30]. Nine reports were at low risk of 
reporting bias [11] [25- 30] [32] [34]. Three reports were at high risk, because either not all 
study results were reported at pre-specified time points or the reported outcome was not pre-
specified in the protocol [9] [23, 24].  Risk of bias due to selective reporting was unclear in 
two studies [31] [33]. 
 
Other sources of bias   
Nine studies were judged low risk of other bias [9] [25- 30] [32] [33]. One study was at high 
risk, the data safely monitoring board recommended enrolment of controls be stopped early 
because of an apparent intervention benefit [11]. Risk of other bias was unclear in 4 studies; 
either baseline characteristics were not compared between study arms, there was a potential 
for misclassification of exposure status or the role of the funder was not described [23,24] 
[31] [34]. 
 
Stellenbosch University  https://scholar.sun.ac.za
107 
 
 
Figure 1. Risk of bias for each domain per study 
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Figure 2. Risk of bias graph for each domain across all studies 
 
Effects of interventions 
Except where specified, results are from combined data from HIV-infected and HIV-
uninfected infants. Wherever publications presented findings separately for HIV-uninfected 
infants we report these. For characteristics of included studies see Additional Table 1. 
 
1. Breastfeeding versus formula feeding 
One RCT [28] and three prospective cohort studies [32- 34] compared growth and non-HIV 
infections outcomes between breast and formula fed HIV-exposed infants. We report the 
RCT and cohort studies separately.  
 
Mbori-Ngacha et al. randomly assigned mother-infant pairs to breast or formula feeding 
groups [28].  Cumulative HIV-infection rates by 2 years of age were 37% and 21%, 
respectively. 
 
Becquet et al. compared infants whose mother chose  breastfeeding with rapid transition to 
formula feeding after 4 months of age to infants whose mothers chose  exclusively formula 
feeding [32]. HIV transmission rates at 18 months were 5% and 1% among breast and 
formula fed infants, respectively. 
 
Kindra et al. compared outcomes of infants whose mothers elected to either breastfeed or 
formula feed.  By 6 weeks of age, HIV transmission rates were 7.9% and 4% among breast 
and formula fed infants, respectively [33]. 
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Venkatesh et al. compared rates of infant hospitalizations associated with infectious 
morbidity among infants whose mothers elected to breast or formula feed [34]. They 
documented HIV transmission rates of 18.4% and 13.2% among breast and formula fed 
infants, respectively by 3 months. 
 
Outcomes 
Growth 
Kindra et al. found no difference in z-scores between breast and formula fed infants at 9 
months of age [33]. 
 
Malnutrition 
Mbori-Ngacha et al. defined malnutrition as a weight-for-height z-score value 2 SD below the 
mean.  Becquet et al. defined malnutrition as an observation of either no change or a 
decrease in anthropometric measurements between study visits. Neither study found a  
statistically significant difference in  malnutrition risk between  breast and formula fed infants 
(RR = 0.63; 95% CI 0.36 to 1.12) and (HR = 1.35; 95% CI 0.93 to 2.0) [28] [32]. 
 
Respiratory tract infections 
Mbori-Ngacha et al. do not describe how upper respiratory tract infections were defined [28]. 
The trial found no difference in rates of respiratory infections between breast and formula fed 
infants (HR = 1.00; 95% CI 0.90 to 1.11) [28].   
 
Becquet et al. defined acute respiratory infection as cough, fever, and focal pulmonary 
findings [32]. Venkatesh et al. used WHO ICD-10 criteria to classify respiratory infections 
associated with hospitalizations [34]. The pooled estimate from these observational studies 
suggests a lower incidence of respiratory infections in breast than formula fed infants (HR = 
0.65; 95% CI 0.41 to 1.00) [32] [34]. After adjusting for HIV status, breastfed infants were 
40% less likely to develop respiratory infections (HR = 0.60; 95% CI 0.36 to 0.98) [32]. 
 
Diarrhoea 
Diarrhoea was defined as passage of 3 or more watery stool per 24-hour period for at least 2 
days. Mbori-Ngacha et al. found no difference over 2 years between breast and formula fed 
infants either when including both HIV-infected and HIV-uninfected infants (HR = 1.11; 95% 
CI 0.91 to 1.43) or in HIV-uninfected infants alone (HR = 1.11; 95% CI 0.83 to 1.43) [28]. 
Venkatesh et al reported similar findings (HR = 0.50 95% CI 0.15 to 1.70 ) as Mbori-Ngacha 
et al. Becquet et al. and Kindra et al. differ from Mbori-Ngacha et al and Venkatesh et al. 
Both studies found that breastfed infants were at lower risk for diarrhoea (RR = 0.31; 95% CI 
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0.13 to 0.74) [33], the risk was significantly lower for breastfed infants after adjusting for HIV 
status (HR = 0.74; 95% CI 0.57 to 0.97) [32]. 
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2. Breastfeeding with extended ARV prophylaxis versus short-course ARV 
prophylaxis  
A clinical adverse event is defined as any health-related reaction or effect experienced by a 
study participant. Serious clinical adverse events (SAEs) in infants were assessed as safety 
endpoints in studies comparing differing postnatal ARV prophylaxis. Five studies compared 
incidence of SAEs between infants exposed to different combinations of extended and short-
course ARV prophylaxes during breastfeeding [9] [11] [26, 27] [30]. We use the term 
"extended ARV prophylaxis" to refer to interventions involving ARVs given for longer 
duration than the (short-course) peri-partum prophylaxes that were standard of care at the 
time the studies were conducted. Important assumptions were made for interventions in this 
comparison. First, Jamieson et al. and the Kesho Bora Study included maternal ARV 
interventions in their studies. Since mothers were breastfeeding while receiving the 
intervention, infants would be ingesting ARVs in breast milk. On this basis, we felt these 
interventions could reasonably be compared with ARV interventions administered directly to 
infants. This assumption is supported by findings of Shapiro et al., that concentrations of 
NVP, lamivudine and ZDV in breast milk of HIV-infected women receiving HAART are similar 
to or higher than their serum concentrations, and that infant serum NVP concentrations were 
sufficient to inhibit HIV-1 replication [35]. Second, the studies by Jamieson et al. and 
Kumwenda et al. each tested two extended ARV regimens against a standard short-course 
regimen. We felt that the two extended ARV interventions in each study were sufficiently 
similar to combine the results for comparison with the short-course ARV group. 
 
Four studies [9] [11] [27] [30] used standard Division of AIDS toxicity tables to grade severity 
of SAEs. One study [26] used the WHO International Classification of Disease (ICD-10) 
criteria. All five studies reported rates of SAEs without stratifying by infants' HIV status. 
 
Coovadia et al. randomly assigned infants who had received 6 weeks of once-daily NVP to 
continue a once-daily NVP prophylaxis or placebo until 6 months of age [30]. Infants were 
followed-up until 18 months of age. At 12 months of age HIV transmission rates were 3.6% 
in the placebo group and 2.8% in the NVP group. 
 
Gray et al. compared ZDV given to infants for the first six weeks of life to  single dose (sd)  
NVP at delivery [26]. Cumulative HIV transmission rates at 12 weeks were 14.3% in the sd 
NVP group and 18.1% in ZDV group. 
 
Jamieson et al. compared a control group of mothers given sd NVP during labour or at 
delivery, and mothers and infants receiving ZDV and lamivudine for 1 week, to two extended 
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ARV groups: postnatal either the mothers received HAART or infants received daily NVP 
until 28 weeks of age [11]. At 48 weeks of follow-up, HIV transmission rates were 7% in the 
control group and 4% in both extended ARV groups. We combined the extended ARV 
groups to allow pairwise comparison with the control group. 
  
In the Kesho Bora Study [27] mothers received HAART until weaning or a maximum of 6.5 
months post-partum (extended ARV group) or ZDV during pregnancy plus sd  NVP at onset 
of labour (short-course ARV group) [27]. By 1 year of age 5.4% of infants in the extended 
ARV group became HIV-infected compared to 9.5% in short-course ARV group. 
 
Kumwenda et al. compared sd NVP and ZDV given to infants for the first week of life (control 
group) to 14 weeks of NVP (extended NVP group) or 14 weeks of NVP plus ZDV (extended 
NVP plus ZDV group) [9]. At 9 months of age HIV transmission rates were 10.6%, 5.2% and 
6.4% in the control, the extended NVP and the extended NVP plus ZDV groups, 
respectively. We combined the two extended ARV groups for pairwise comparison with the 
control group. 
 
Outcomes 
Growth faltering 
The risk of growth faltering was 12% higher in infants on extended ARV prophylaxis than 
short-course ARV prophylaxis (RR = 1.12; 95% CI 0.83 to 1.50) [9] [11] [27] (Figure 3). 
 
 
Figure 3. Forest plot of breastfeeding with extended ARV prophylaxis vs. short-course 
ARV prophylaxis: Growth faltering 
 
Pneumonia 
The mean difference (MD) in incidence of pneumonia in the extended ARV prophylaxis 
group was  -0.01 (95% CI -0.02 to -0.00) [9] [11] [26] [27] (Figure 4). The MD was  -0.02 
(95% CI -0.03 to -0.00) when we excluded the study with a high attrition rate.  Risk of 
pneumonia was similar between the groups in Coovadia study [30]. 
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Meningitis 
There was no difference in meningitis incidence between extended and short-course ARV 
prophylaxis groups [9] [11].  
 
Gastroenteritis 
There was no difference in rates of gastroenteritis  between extended and short-course ARV 
prophylaxis (MD = 0.01; 95% CI -0.01 to 0.02) [9] [11] [26, 27] (Figure 5). Coovadia et al. 
found no difference in risk of gastroenteritis between the two group (RR = 0.90; 95% CI 0.61 
to 1.33) [30]. 
 
Sepsis 
Incidence of sepsis was similar between intervention groups [9]. 
 
 
 
Figure 4. Forest plot of breastfeeding with extended ARV prophylaxis vs. short-course 
ARV prophylaxis: Pneumonia   
 
 
Figure 5. Forest plot of breastfeeding with extended ARV prophylaxis vs. short-course 
ARV prophylaxis: Gastroenteritis 
 
3. Early breastfeeding cessation versus standard duration of breastfeeding 
Two reports from a single RCT presented growth and diarrheal morbidity outcomes in HIV-
exposed uninfected infants whose mothers were randomly assigned to stop breastfeeding at 
4 months (intervention group) or to continue breastfeeding for as long as they wished, with 
Stellenbosch University  https://scholar.sun.ac.za
114 
 
the median duration being 16.2 months (control group) [23] [25]. HIV transmission rates 
were 21.4% and 25.8% in the intervention and control groups, respectively. 
 
Outcomes 
Growth 
Weight-for-age z-scores at 2 years of age were similar between infants stopping 
breastfeeding early compared to continuing for a longer duration (MD = 0.12; 95% CI -0.10 
to 0.34) [23]. 
 
Prolonged diarrhoea 
Diarrhoea lasting for at least 7 days was defined as prolonged [25]. During the 7-24 months 
age period, the odds of having an episode of prolonged diarrhoea when breastfeeding was 
stopped early were almost twice that of breastfeeding for a longer duration (OR = 1.70; 95% 
CI 1.28 to 2.26). 
 
4. Chemically or biologically acidified formula versus standard formula 
 
Velaphi et al. compared infectious morbidity and growth between HIV-exposed uninfected 
infants receiving chemically or biologically acidified formula and those receiving standard 
formula for the first four months [31]. 
 
Infants were randomly assigned to four groups: 
1. Non-acidified (standard) whey-adapted starter formula 
2. Chemically acidified standard formula, where acidification was achieved through 
addition of L(+) lactic acid  
3.  Chemically acidified standard formula with Bifidobacterium lactis CNCM I-3446 
added 
4. Biologically acidified standard formula, where acidification was achieved through 
bacterial fermentation  
We combined the two chemically acidified formula groups and the biologically acidified 
formula group for pairwise comparison with the standard formula group. 
 
Outcomes 
Growth 
Z-scores were calculated based on growth charts from the Centre for Disease Control and 
Prevention (CDC) and were presented up to 4 months of age. Head circumference-for-age 
z-scores were significantly higher in infants who received acidified formulas compared to 
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infants who received standard formula (MD = 0.31; 95% CI 0.15 to 0.48). The study found no 
significant differences in WLZ-scores (MD = 0.09; 95% CI-0.16 to 0.34, LAZ-scores (MD = 
0.08; 95% CI -0.15 to 0.30) and WAZ-scores (MD = 0.18; 95% CI -0.05 to 0.41) between 
study groups. 
 
Bronchopneumonia and gastroenteritis 
The authors do not describe how infectious outcomes were defined. Incidence of 
bronchopneumonia (MD 0.12; 95% CI -0.03 to 0.27) and gastroenteritis (MD -0.07; 95% CI -
0.17 to 0.02) between birth and 6 months of age were similar between infants on acidified 
formula and those on standard formula. 
 
5. Concentrated formula versus Standard formula 
 
Winter et al. assessed growth in HIV-exposed uninfected infants randomly assigned to 
receive either concentrated infant formula 87 kcal/100mL or standard formula 67 kcal/100mL 
[29].  
 
Outcomes 
Growth 
Z-scores were calculated using the 2000 National Centre for Health Statistics paediatric 
growth references. Mean WAZ-scores was significantly higher for infants on concentrated 
formula than standard formula (MD = 0.12; 95% CI 0.04 to 0.20). We found no significant 
differences in WLZ-scores (MD = 0.11; 95% CI -0.01 to 0.23), LAZ-scores (MD = 0.03; 95% 
CI -0.06 to 0.12), and head-circumference-for-age z-scores (MD = -0.03; 95% CI -0.11 to 
0.05). 
 
6. Chemically acidified formula with or without prebiotics and nucleotides 
 
Growth and infectious morbidity were compared in HIV-exposed, uninfected infants on 
chemically acidified formula alone and  with prebiotics and nucleotides [24]. Infants were 
randomly assigned to three study groups and followed-up until 6 months of age: 
1. Chemically acidified formula (control)  
2.  Chemically acidified formula with prebiotics (a blend of short-chain and long chain 
fructo-oligosaccharides)  
3. Chemically acidified formula with prebiotics and nucleotides (a blend of cytidine, uridine, 
adenosine and guanosine monophosphates)   
Chemical acidification was achieved as in [31]. 
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We combined outcomes from infants in groups 2 and 3 to allow pairwise comparisons with 
group 1. 
 
Outcomes 
Growth 
Z-scores were calculated using the 2000 CDC growth charts. The primary study report 
presented summary data and corresponding 95% CIs in graph format. We estimated mean 
z-scores and SDs from the graphs. 
Mean WAZ-scores (MD = 0.08; 95% CI -0.15 to 0.31) and LAZ-scores (MD = -0.14; 95% CI -
0.39 to 0.1) were similar in all groups.  
 
Table 2.  Breastfeeding compared to formula feeding for HIV-exposed infants 
Outcomes Relative effect 
(95% CI) 
Number of 
Participants 
(studies) 
Quality of the 
evidence 
(GRADE) 
Malnutrition RCT RR 0.63  
(0.36 to 1.12) 
371 
(1) 
⊕⊕⊝⊝ 
low*,ⱡ 
Diarrhoea ‘Cohort study, 
effect up to 2 years of age’ 
HR 0.74  
(0.57 to 0.97) 
557 
(1 ) 
⊕⊕⊕⊝ 
moderate¶,* 
Diarrhoea ‘Cohort study, 
effect up to 3 months of 
age’ 
RR 0.31  
(0.13 to 0.74) 
127 
(1) 
⊕⊝⊝⊝ 
low¶,† 
Respiratory infections RCT HR 1  
(0.9 to 1.11) 
371 
(1) 
⊕⊕⊝⊝ 
low*,ⱡ 
Respiratory infections 
Cohort 
HR 0.60 
(0.36 to 0.98) 
557 
(1) 
⊕⊕⊕⊝ 
moderate¶ 
Diarrhoea RCT HR 1.11  
(0.91 to 1.43) 
371 
(1) 
⊕⊕⊝⊝ 
low*,ⱡ 
RR: Risk ratio; HR: Hazard ratio; *Study had some methodological limitations, ⱡWide confidence 
interval and fails to exclude the null effect, ¶Observed breastfeeding effect was considered clinically 
important, †Sample size was too small 
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Table 3. Breastfeeding with extended ARV compared to breastfeeding with short-
course ARV prophylaxis for HIV-exposed infants 
Outcomes Illustrative comparative risks˟ (95% CI) Relative 
effect 
(95% CI) 
Number of 
Participants 
(studies) 
Quality of 
the 
evidence 
(GRADE) 
Assumed risk Corresponding risk 
 
Breastfeeding with short 
course ARVs  
Breastfeeding with 
extended ARVs    
Growth 
faltering 
Study population RR 1.12  
(0.83 to 
1.5) 
5719 
(3) 
⊕⊕⊕⊝ 
moderateⱡ,† 32 per 1000 36 per 1000 
(27 to 48) 
Pneumonia The average incidence 
of pneumonia ranged 
across control groups 
from  
0.03 to 0.11  
The average incidence of 
pneumonia in the 
intervention groups was 
0.01 lower 
(0.02 lower to 0.00 higher) 
 6437 
(4) 
⊕⊕⊕⊝ 
moderateⱡ,* 
Meningitis The average incidence 
of meningitis ranged 
across control groups 
from  
0.0089 to 0.0147 
The average incidence of 
meningitis in the 
intervention groups was 
0 higher 
(0.01 lower to 0.00 higher) 
 4914 
(2) 
⊕⊕⊝⊝ 
low¶,ⱡ 
Gastroenteritis The average incidence 
of gastroenteritis 
ranged across control 
groups from  
0.02 to 0.07  
The average incidence of 
gastroenteritis in the 
intervention groups was 
0.01 higher 
(0.01 lower to 0.02 higher) 
 6437 
(4) 
⊕⊕⊕⊝ 
moderateⱡ,† 
 
The assumed risk was based on the mean control group risk if there was one study included or on 
mean range in control group risk across studies, otherwise. The corresponding risk (and its 95% CI) is 
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 
95% CI). CI: Confidence interval; RR: Risk ratio. ⱡThere were too few studies to assess publication 
bias, †CI failures to exclude appreciable harm, *Point estimates vary widely, ¶There were very few 
events 
 
 
Discussion 
Summary of main findings 
We reviewed findings from 7 RCTs and 3 cohort studies evaluating effects of various 
postnatal interventions for prevention of MTCT of HIV. 
 
 From our meta-analysis, breastfeeding appears to decrease the risk of respiratory infections 
by 35%, when infant feeding mode is self-selected and when not considering infant HIV 
status. However, this finding was not supported by the only RCT reporting on this 
comparison. There is moderate quality evidence that the risk of respiratory infection remains 
lower (by 40%) in breastfed infants through to 2 years of age, after adjusting for infant HIV 
status [32]. 
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The evidence from this review is inconsistent on the effect of breast versus formula feeding 
on diarrhoeal morbidity. In three observational studies, breastfeeding significantly reduced 
risk of diarrheal morbidity in early life [33, 34], and,  of diminished magnitude until the second 
birthday [32]. We graded this evidence of moderate quality. A randomised trial found no 
significant difference in diarrheal morbidity between breast- and formula fed infants up to 2 
years of age [28]. This trial was not powered to test equivalence of diarrheal morbidity in the 
two arms. Therefore, it is important to avoid interpreting the lack of statistical significance as 
evidence of equivalent risk. Breastfeeding is expected to reduce diarrhoea incidence. There 
are a few possible explanations why this was not observed in this trial. HIV transmission was 
higher among breastfed than formula fed infants, probably obscuring the protective effect of 
breastfeeding. However, even when results from HIV-uninfected infants were analysed 
separately, no significant difference was found. A limitation of performing this type of sub-
analysis is that the comparison groups are no longer “as randomized”, therefore not 
necessarily comparable in baseline characteristics, thus possibly obscuring the true effect of 
breastfeeding. In our opinion, the most likely explanation is that as 30% of mothers assigned 
to the formula group had breastfed their infants [28], some protective effect of breast milk 
occurred in the formula group.  
 
In the only RCT comparing breast versus formula feeding, the risk of malnutrition was 37% 
lower in breastfed infants. Though not statistically significant, the reduction in risk may be 
clinically important because the 95% CI includes strongly protective values at the lower limit 
and excludes values indicating appreciable harm from breastfeeding at the upper limit. Also, 
high HIV transmission rates in breastfed infants would be expected to attenuate any 
protective effect of breastfeeding, pulling the estimate towards the null. On the other hand, 
high rates of non-compliance  in the formula-feeding group could be confounding this result. 
This evidence is judged of low quality. Further research comparing the nutritional outcomes 
of breast versus formula fed infants of HIV-infected mothers is warranted. 
 
We found moderate quality evidence that breastfeeding with extended ARV prophylaxis is 
associated with fewer pneumonia episodes compared to breastfeeding with short-course 
ARV prophylaxis in HIV-exposed infants. The causal explanation remains unclear. If 
evidence of this association continues to accumulate, further investigation to explain the 
underlying biological mechanisms should be prioritised. However, high HIV transmission 
rates in infants on short-course ARV prophylaxis, especially in studies contributing 
substantial sample size to our meta-analysis [9] [27], could explain the higher incidence of 
pneumonia experienced by infants in this group.  
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Our meta-analysis shows a modestly increased risk for growth faltering among infants in the 
extended ARV group. This estimate has a wide CI, which includes the null effect. However, 
there is some evidence that infants exposed to ARV therapy in utero, compared to post-natal 
ZDV, have reduced growth up to 2 years of age (36) . Therefore, growth of infants exposed 
to post-natal ARVs should further studied. 
 
We did not find the rates of any other SAEs to differ significantly between infants in the 
extended and short-course ARV prophylaxis groups. We do not believe that inadequate 
follow-up explains the lack of observed differences. In addition, with sample sizes of 
between 1898 and 5719 for different outcomes, it seems reasonable to conclude that 
extended ARV prophylaxis does not increase the risk for HIV-exposed infants to experience 
non-HIV infections outcomes compared to short-course ARV prophylaxis.  
 
Conclusions       
Implications for practice 
Breastfeeding may reduce the risk of diarrheal morbidity, respiratory tract infections and 
malnutrition compared to formula feeding in HIV-exposed infants. Extended ARV prophylaxis 
and formula feeding effectively reduce or prevent late postnatal transmission of HIV infection 
(19). The magnitude of absolute benefit of breastfeeding combined with extended ARV 
prophylaxis may be sufficient to improve survival of children.  
 
The benefits of breastfeeding with extended ARV prophylaxis must be weighed against the 
risk of HIV transmission through breast milk when making decisions about feeding HIV-
exposed infants. Baseline risks, such as maternal viral load,  safety of ARVs and sustained 
adherence should also influence decisions. Uptake of exclusive breastfeeding is reportedly 
poor in most African settings [37, 38]. Sub-optimal infant feeding practices are likely to 
modify the effectiveness of breastfeeding with ARV prophylaxis, especially in normal practice 
settings. Continuous evaluation of these interventions to determine whether their 
effectiveness remains clinically important should be a priority as these interventions are 
introduced in to clinical practice. 
 
 Implication for research 
Large prospective cohort studies with sufficient length of follow-up are justified to investigate 
the effectiveness of postnatal interventions for PMTCT of HIV in normal practice settings. 
The studies should include infectious morbidity and infant growth as primary outcomes. 
Effects of specific infant formulas on growth require further evaluation. 
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Appendix 2: 
Chart Extraction guide 
 
• Section A (History) data to be collected as close to admission as possible.  Any 
unrecorded information ask mom directly if she is available. 
• Section B-E data to be collected at end of admission. 
• Infants length and TB culture results may need to be followed up at a later date. 
 
General Admission Details 
1. Study ID number: or study sticker can be placed here 
2. Hospital: circle appropriate hospital or specify if not listed. Indicate the hospital at first 
presentation. 
3. Date of admission: all dates with months in letters e.g. Jan, Feb, Mar 
4. Date of  final discharge home: if referred to another hospital, this is the final date of 
discharge home, not date of transfer from presenting hospital to referral hospital  
5. Problem list: taken from the doctor’s daily notes and the discharge summary; DO 
NOT include HIV exposure in the list; can be more than 6 if applicable 
6. Referral to another hospital: indicate which hospital 
7. ICU care: could be ICU at secondary or tertiary hospital 
 
A. History on Admission 
Systemic Enquiry: 
1. Cough < 14/7: ok if duration of cough not specified but rest of hx < 14/7  
2. Cough > 14/7: ok if has received broad spectrum antibiotics and not responded to 
them with a vague duration or duration >9 but < 14/7 
3. Fever < 14/7: ok if duration of fever not specified but rest of hx < 14/7 
4. Coryza or rhinitis: “runny nose” ok 
5. Difficulty breathing: “short of breath”, “fast breathing” ok 
6. Apnea episodes: “stopped breathing”, “turned blue” ok 
7. Vomiting everything: “persistent vomiting” ok, vomiting all source of nutrition i.e. all 
milk < 6 months, all milk and solids > 6 months ok 
8. Liquid stools: more unformed than usual, with increased number, “runny stools”, 
“loose stools”, “diarrhea stools”, “watery stools” ok 
a. <14/7 ok if duration of diarrhea not specified but rest of hx < 14/7 
9. Bloody stools: “any blood in stools”, “dysentery” ok 
10. Convulsions: “seizures” ok 
11. Fatigue or reduced playfulness: “less active than usual”, “more sleepy than usual” ok 
12. Weight: to inspect from RTHB if available; if RTHB not available then take from 
admission notes 
Past Medical History: 
This section should be completed from hospital notes and MIHS source document of study 
doctors assessment 
13. Known congenital abnormality: includes genetic syndromes e.g. Trisomy 21 (Down 
Synd), Fetal Alcohol Spectrum Disorder; specify congenital abnormality 
14. Known chronic acquired disease: includes chronic conditions that are not congenital 
e.g. cerebral palsy, nephrotic syndrome, seborrheic dermatitis or atopic eczema 
15. Known TB contact: an adult who has had pulmonary tuberculosis in the last 12 
months and who lives in same household as child or someone with whom the child is 
in contact for long periods 
B. Physical Examination 
• Yes, < 48hrs = sign was present but for less than 48 hrs 
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• Yes, > 48 hrs = sign was present for 48 hrs or more (consider sign to be present > 48 
hours if noted on two consecutive daily morning rounds notes) 
• No = sign was never present 
• Unknown = sign was not reported on in hospital notes 
• 1-5 below will be recorded in nursing notes 
 
1. Weight: recorded in casualty observations or first ward observations on admission 
2. Length: may not be well recorded; if length unknown extrapolate from length at study 
visit on either side of admission 
3. MUAC: unlikely to be present, but record if is 
4. Temperature: from nursing observation chart for entire admission 
5. Tachypnea for age: 0-2 months > 60bpm; >2-12 months > 50bpm; from nursing 
observation chart for entire admission 
6. Acutely unwell: “shocked” ok 
7. Irritable: only if noted on examination and persistently irritable > 48 hours 
8. Cervical lymph node mass: ok if just noted to be > 2x2cm or “large” 
9. Conjunctivitis: includes eye discharge 
10. Skin pinch 1-2sec: capillary refill time (CRT) 1-2 sec ok 
11. Skin pinch > 2 sec: CRT > 2 sec ok 
12. Unable to eat orally: only important if oral ulceration present 
13. Diffuse vesicular rash: “blistery rash” ok 
14. Visible ear discharge: “pus in ear canal” ok 
15. Inflamed tympanic membrane: “red”, “hyperemic” ok 
16. Lower chest wall indrawing, recession: retractions ok 
17. Engagement of abdominal muscles on expiration: “prolonged expiration” ok 
18. Liver ptosis: “liver pushed down” ok 
19. Stridor on inspiration only: Grade 1 stridor/croup ok 
20. Stridor on inspiration and expiration: Grade 2 or > stridor/croup ok 
21. Neck stiffness: “meningism” ok 
22. Spinal angulation: “spinal deformity” ok 
 
C. Investigations 
 
 Laboratory Investigations (HIV Test & TB Microbiology) 
1. Done-yes: means yes investigation done during admission 
2. Done-no: means no investigation not done during admission 
3. Result: positive or negative i.e. mTB culture positive, mTB culture negative, HIV PCR 
positive, HIV PCR negative 
 
Chest X-Ray 
1. Done-yes: means yes investigation done during admission 
2. Done-no: means no investigation not done during admission 
3. Result: next to each of the statements “Suggestive of PTB” or “Bilateral 
Hyperinflation”, indicate positive if doctor’s notes contained such an affirmative 
statement with regards to PTB or hyperinflation or negative if doctor’s notes did not 
contain such an affirmative statement or contained a negative statement with regards 
to PTB or hyperinflation. 
 
D. Treated For 
 
Only record if treatment initiated for the condition during this admission.  
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1. For all TB diagnoses: if listed on discharge summary and discharged on TB 
medication (RIF, INH, PZA +/- ETH or EMB) 
2. Extrapulmonary TB: specify type e.g. TB meningitis, TB pericarditis, abdominal TB 
3. Meningitis: treated for viral or bacterial meningitis whether confirmed on culture or 
not; don not include TB meningitis here 
4. Bacterial septicemia: > 28 days old; only blood culture positive and specify organism 
5. Presumed septicemia: or “presumed sepsis”; > 28 days old; treated for bacterial 
sepsis but blood culture negative or not done 
6. Urinary tract sepsis: if > 2 organisms cultured on urine sample, unlikely to be from a 
sterile urine specimen (discuss with Amy) 
7. Neonatal sepsis without meningitis: only < 28 days; “presumed neonatal sepsis” ok 
8. Neonatal sepsis with meningitis: only < 28 days; with abnormal CSF 
9. Other pediatrician/neonatologist diagnosed congenital infection: specify the infection 
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Appendix 3: 
Infectious cause hospitalization classification and grading definitions 
A. Respiratory Tract Infections  
 
# Criteria for pneumonia and tuberculosis can be fulfilled concurrently for the same event 
# Criteria for pneumonia and bronchiolitis cannot be fulfilled concurrently for the same event 
 
1. Pneumonia   
 
• History of cough or difficulty breathing 
PLUS 
• Tachypnea for age (on presentation/admission)  
 [0-2 months > 60bpm, 2-12 months > 50bpm] 
OR 
• Nasal prong or nasal cannula O2 required for transfer to hospital 
WITHOUT 
• Wheeze 
Severe  
At least 1 of the following  
 Lower chest wall indrawing or nasal flaring 
 Not able to drink or breastfeed 
 Vomiting everything 
 Convulsions during this illness 
 Lethargic or unconscious  
 O2 saturation < 92% on room air measured by pulse oximeter 
 NPO2 required to keep O2 saturation > 92 % measured by pulse oximeter 
Mild-moderate  
No features of severe pneumonia 
 
2. Tuberculosis  
• Started on TB treatment in hospital (none of below criteria necessary) 
OR 
• A close TB contact (an adult who has had PTB in last 12 months, who lives in the 
same household as child or someone with whom the child is in contact for long 
periods) 
PLUS 2 or more of the following 
 
* General Danger Signs 
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• Persistent non-remitting cough or wheeze for > 2 weeks that has not responded to 
broad spectrum antibiotics for community acquired pneumonia 
• Documented loss of weight, no weight gain, or unsatisfactory weight gain (i.e. not 
following own curve or crossing centiles downwards) 
• Fatigue or reduced playfulness 
• Persistent fever > 2 weeks 
• Painless enlarged mass of matted cervical lymph nodes (> 2x2 cm), without visible 
local cause on scalp or response to oral antibiotics 
AND/OR 
• Abnormal chest X-ray suggestive of PTB (enlarged hilar lymph nodes; airway 
compression; lung parenchymal disease; miliary dissemination) 
OR 
• Bacteriological confirmation of TB on sputum, gastric aspirate or lymph node fine 
needle aspiration biopsy 
 
Severe  
At least 1 of the following 
 Severe respiratory distress – tachypnea for age PLUS at least 1 of lower chest wall 
indrawing or O2 required 
 Wheezing (low pitched monophonic) not responding to bronchodilator 
 Headache, neck stiffness, drowsiness, irritability, convulsions 
 Hepatosplenomegaly (age defined) 
 Peripheral oedema 
 Distended abdomen with or without ascites 
 Angulation of the spine/gibbus 
OR 
Hospital diagnosed extrapulmonary or miliary TB 
 
Mild-moderate 
No features of severe tuberculosis 
 
3. Bronchiolitis  
 
• History of cough or difficulty breathing 
PLUS 1 of the following 
• Wheeze on history or physical exam 
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• Evidence of hyperinflation on physical exam (liver ptosis or reduced cardiac dullness 
on percussion) 
• Evidence of hyperinflation on chest X-ray (> 8 posterior ribs above the diaphragm) 
Severe  
At least 1 of the following  
 Tachypnea for age [0-2 months > 60bpm, 2-12 months > 50bpm] 
 Lower chest wall indrawing, nasal flaring or engagement of abdominal muscles on 
expiration 
 Not able to drink or breastfeed 
 Vomiting everything 
 Convulsions during this illness 
 Apnoea on history or witnessed 
 Lethargic or unconscious  
 O2 saturation < 92% on room air measured by pulse oximeter 
 NPO2 required to keep O2 saturation > 92 % measured by pulse oximeter 
 
Mild-moderate if 
No features of severe bronchiolitis 
 
B. Diarrhoea  
 
1. Acute Diarrhoea 
• Liquid stools (more unformed than usual) with increased number of stools < 14 days 
Severe 
At least 2 of the following 
 Lethargic or unconscious 
 Sunken eyes 
 Not able to drink or drinking poorly 
 Skin pinch takes > 2 seconds to return to normal 
Mild-moderate 
No signs of severe 
 
2. Persistent Diarrhoea 
• Liquid stools (more unformed than usual) with increased number of stools > 14 days 
Severe 
At least 2 of the following (any dehydration) 
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 Lethargic or unconscious 
 Restless or irritable 
 Sunken eyes 
 Not able to drink, drinking poorly, drinking eagerly, thirsty 
 Skin pinch takes > 1 second to return to normal 
OR 
 Any loss of weight 
Mild-moderate 
No visible dehydration or weight loss 
 
3. Dysentery 
• Any blood in the stool 
Severe 
At least 1 of the following 
 Age < 12 months 
 Any dehydration present 
 
Mild-moderate 
No features of severe dysentery 
 
C. Skin and mucocutaneous infections 
 
1. Measles 
• Fever AND diffuse maculopapular rash 
PLUS 1 of 
• Cough, coryza or conjunctivitis 
Severe 
At least 1 of the following 
 Pneumonia (as previously defined) 
 LTB (as previously defined) 
 Diarrhoea (as previously defined) 
 Any general danger signs* 
Mild-moderate 
No features of severe measles 
2. Varicella Zoster 
• Fever AND diffuse vesicular rash 
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Severe 
At least 1 of the following 
 Pneumonia (as previously defined) 
 LTB (as previously defined) 
 Any general danger sign* 
Mild-moderate 
No features of severe varicella zoster 
 
3. Non-specific viral exanthema 
• Fever AND rash 
AND 
• Doesn’t meet criteria for measles or varicella zoster 
Severe 
Presence of any general danger sign* 
Mild-moderate 
No features of severe viral exanthem 
 
4. Stomatitis 
• Erythema AND ulceration of oral mucosa  (lips, gingiva or tongue) 
Severe 
At least 1 of  
 Stridor 
 Unable to eat orally, requiring nasogastric, orogastric or intravenous fluids 
Mild-moderate 
No features of severe stomatitis 
 
5. Bacterial Skin Infection 
At least 1 of 
• Impetigo (diffuse pustular eruption) 
• Abscess 
Severe 
Presence of any general danger sign* 
Mild-moderate 
No features of severe bacterial skin infection 
 
D. Central nervous system infections 
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1. Meningitis 
 
• Hospital diagnosis of meningitis based on clinical features and abnormal 
cerebrospinal fluid 
 
E. Invasive bacterial infections 
 
Hospital diagnosis of any one of the following: 
 
1. Neonatal sepsis – diagnosed before 28 days of life 
a. confirmed – blood culture positive  
b. presumed – no positive blood culture, but treated for neonatal sepsis with a 
minimum duration of admission of 7 days 
2. Postneonatal sepsis – diagnosed after 28 days of life 
a. confirmed - blood culture positive  
b. presumed – no positive blood culture, but treated for presumed bacterial 
sepsis with a minimum duration of admission of 7 days  
3. Urinary tract sepsis – sterile urine culture positive 
4. Septic arthritis – specialist diagnosis 
5. Osteomyelitis – specialist diagnosis 
6. Pyomyositis – specialist diagnosis 
 
F. Congenital Infections 
 
Hospital diagnosis of any one of the following  
1. Congenital tuberculosis 
2. Congenital syphilis 
3. Congenital CMV 
4. Neonatal Herpes Simplex Virus infection 
5. Other paediatrician diagnosed congenital infection 
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Appendix 4: 
Factors Associated With HIV-infected Mothers' Perceptions Of  And Reactions To, Infant 
Feeding Choices In South Africa 
Tuesday, 19 August 2014 
Exhibit hall (Dena'ina Center) 
Moleen Zunza, MA , Stellenbosch University, Stellenbosch, South Africa  
Monika Esser, MD , Stellenbosch University, Tygerberg, South Africa  
Julie. A Bettinger, PhD , University of British Columbia, Vancouver, BC, Canada  
Mark.F Cotton, PhD , Stellenbosch University, Tygerberg, South Africa  
INTRODUCTION: As Prevention of mother-to-child transmission transitions towards 
universal combination antiretroviral therapy (cART), the incidence of breastfeeding is 
increasing and formula feeding decreasing for HIV-exposed infants in the Western Cape 
province of South Africa. In a prospective cohort study (the Mother-Infant Health Study) we 
are assessing infant feeding practices in HIV exposed infants.  This sub-study assessed HIV 
infected mothers’ perceptions of and reactions to feeding their infants. The aim of this study 
was to capture, from a phenomenological perspective, a socially constructed view of HIV 
infected mothers’ lived experiences regarding feeding their infants.  
METHODS: Through application of Interactive Qualitative Analysis, two separate focus 
group discussions, a) breastfeeding mothers (n = 7) and b) formula feeding mothers (n =8) 
were conducted to determine factors associated with their feeding experiences. The focus 
group discussions were conducted in November 2013. Mothers reflected on their thoughts, 
beliefs, and experiences regarding feeding their infants. In depth individual interviews (n = 
24) based on focus group responses were then conducted to explore the personal meaning, 
relevance, and life history examples of the themes with the mother.   
RESULTS: Preliminary findings revealed that the main factors comprising experiences of 
breastfeeding HIV positive mothers were: advice on breastfeeding, reasons for wanting to 
breastfeed, choosing a feeding option that could make a baby sick (HIV infected), 
discouragement of breastfeeding, and challenges of breastfeeding. Main factors that 
described HIV positive formula feeding mothers experiences were: advice on formula 
feeding, consideration of baby’s health, social expectations, disclosure of HIV status, making 
decisions about their own situation and fear of HIV transmission to their infant.   
CONCLUSIONS: Breastfeeding and formula feeding HIV positive mothers had different 
feeding experiences. Factors that describe HIV positive mothers’ infant feeding experiences 
should be explored on how they relate to each other to understand the meaning mothers 
attach to their feeding experiences.  
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Available from: https://wce.confex.com/wce/2014/webprogram/Paper3392.html 
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Appendix 5 
Infant feeding choices and effects on infant morbidity in PMTCT programs transitioning to 
“option b+” in Western Cape, South Africa: The mother infant health study 
Moleen Zunza ,Mark F. Cotton, , Monika Esser  
Introduction Since the discovery of HIV transmission through breast milk more than 30 years 
ago, guidelines for feeding infants born to HIV-infected women have been changing. Despite 
the current recommendations for HIV-infected women to breastfeed with combination 
antiretroviral treatment, there are limited data on morbidity and growth of infants who are 
cared for in normal practice settings. The objective of this study was to determine the effect 
of infant feeding on morbidity and growth among predominantly breastfed and formula-fed 
HIV-exposed over a 12 months period. MethodsWe performed a longitudinal cohort study 
between July 2012 and December 2013 at Kraaifontein Midwife Obstetric Unit. 
Results One hundred eighty three HIV-exposed uninfected infants were included in the 
analysis. Of these, 80 (44%) were in the breastfeeding group and 103 (56%) were in the 
formula feeding group at baseline. The follow-up rate was 28 of 80 (35%) in the 
breastfeeding group and 47 of 103 (46%) in the formula feeding group. The median (range) 
duration of breastfeeding was 1.93 (0.43 to 12.06) months and that of formula feeding was 
8.94 (0.46 to 12.75) months. There were 37 infection related hospitalizations, twelve of these 
occurred among predominantly breastfed infants and 25 occurred among predominantly 
formula fed infants. The unadjusted and adjusted odd ratio of hospitalization due to major 
infectious morbidity among formula fed children compared to those who were breastfed was 
1.53 (0.56 to 4.18) and 1.10 (95% CI: 0.38 to 3.20). We found no differences in weight-for-
age, length-for-age and weight-for-length z -score between predominantly breastfed and 
predominantly formula fed infants. 
Conclusion Women who chose to breastfeed quickly switched to formula feeding. Infection 
related hospitalizations tended to be fewer among predominantly breastfed infants. PMTCT 
programs need to adopt strategies that improve adherence to prolonged breastfeeding for 
the benefits to be realized at population level. 
Available from: 
http://www.sun.ac.za/english/faculty/healthsciences/aad/Documents/Programme_59th%20A
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